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?????????
Tuberculosis (TB) is a chronic infectious disease that mainly affects the lungs and causes extensive human 
morbidity and mortality. It results from infection with Mycobacterium tuberculosis, a slow-growing 
intracellular pathogen that can replicate and survive inside macrophages. M. tuberculosis relies on the 
specialised ESX-1 secretion system to export virulence factors needed for intracellular spread and 
pathogenesis. The ESX-1 apparatus is a multi-subunit nanomachine composed of ~20 polypeptides including 
membrane proteins, ATPases, proteases, chaperones and substrates. Although many of the individual 
components of this secretion system have been characterised, the overall mechanism underlying ESX-1 
secretion is still far from clear. To obtain a more comprehensive picture of the functioning of the ESX-1 
apparatus, we have studied various components which were largely unexplored in M. tuberculosis. The 
structural component EccE1, the ESX-1 specific protein EspL and the transcriptional regulator WhiB6 have 
been investigated in this thesis using an integrative approach involving genetics, biochemistry, proteomics and 
microscopy. 
We have demonstrated that EccE1 is a membrane- and cell-wall associated protein critical for secretion of 
ESX-1 substrates and M. tuberculosis-mediated cell lysis. Deletion of eccE1 from the chromosome severely 
compromised secretion of EsxA, EsxB, EspA and EspC but not EspB. Localization studies using a florescent-
fusion protein showed that EccE1 localises to the poles of M. tuberculosis in the presence of an active ESX-1 
system.  
Our study also shows that EspL is a cytosolic protein needed for stabilising EspE, EspF and EspH, suggesting 
that it acts as a specific chaperone of the ESX-1 secretion system. Moreover, EspL was shown to interact with 
EspD and to be important for the secretion of ESX-1 substrates. Lack of EspL resulted in a growth defect 
ex vivo, loss of cytotoxicity and reduction of innate cytokine production demonstrating its critical role in 
M. tuberculosis virulence. Analysis of the transcriptional response revealed that the only gene deregulated in 
the absence of espL was whiB6, encoding a transcriptional factor that positively controls ESX-1 genes. To 
explore the role of this regulator in M. tuberculosis virulence, we generated a deletion mutant of whiB6 and 
discovered that its loss resulted in severe reduction of cytotoxicity ex vivo. 
Overall this investigation improves our current understanding of the ESX-1 secretion system and of the 
molecular basis of M. tuberculosis virulence. The increased knowledge of the complex interactions between 
the pathogen and the human host will hopefully translate into new strategies to control the spread of TB. 
 
Keywords:?tuberculosis (TB), Mycobacterium tuberculosis, virulence, ESX-1 secretion system, EccE1, EspL 
and WhiB6.  
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???????
La tuberculose est une maladie pulmonaire infectieuse chronique constituant un facteur de morbidité et de 
mortalité majeur chez l’homme. Elle est principalement causée par un bacille à croissance lente, 
Mycobacterium tuberculosis, qui se multiplient et survie au sein des macrophages grâce à un ingénieux 
système de virulence appelé ESX-1. Ce système de sécrétion permet l’export des facteurs de virulence 
nécessaires à sa multiplication intracellulaire et sa pathogénèse. Le système ESX-1 est une nanomachine 
composée d’une vingtaine de polypeptides incluant des protéines membranaires, ATPases, protéases, 
chaperonnes et leurs substrats. Bien que plusieurs constituants de ce système aient été précédemment 
caractérisés, le mécanisme de sécrétion globale est loin d’être élucidé. Afin d’améliorer notre compréhension 
du système de sécrétion ESX-1, nous avons étudié plusieurs de ses éléments encore non décrit chez 
M. tuberculois. Ce travail de thèse vise à étudier plus particulièrement les rôles déterminant dans le processus 
de sécrétion des protéines EccE1 et EspL situées dans l’opéron codant pour l’appareil de sécrétion ESX-1, et 
du régulateur WhiB6 impliqué dans la régulation des mécanismes de sécrétion, en utilisant une approche 
multidisciplinaire combinant la génétique, la biochimie, la protéomique et la microscopie. 
Tout d’abord, nous avons démontré qu’EccE1 est une protéine associée à la membrane et à la paroi bactérienne 
et qu’elle est essentielle pour la sécrétion des substrats du système ESX-1 ainsi qu’à la lyse des cellules de 
l’hôte. En étudiant les profils de sécrétion de bactéries mutantes possédant une délétion chromosomique du 
gène codant pour la protéine EccE1, nous avons déterminé qu'EccE1 est essentielle pour la sécrétion de quatre 
des principaux substrats d’ESX-1 (EsxA, EsxB, EspA et EspC) mais facultative pour la sécrétion du substrat 
EspB. Grâce à l’utilisation d’une protéine de fusion fluorescente, nous avons également pu localiser EccE1 aux 
pôles de la bactérie et démontrer que la présence des autres gènes de l’opéron est essentielle à cette localisation 
spécifique.  
Dans une deuxième partie, nous avons démontré qu’EspL est une protéine cytosolique essentielle pour le 
fonctionnement du système de sécrétion ESX-1 en jouant un rôle de chaperonne nécessaire pour la stabilité 
des protéines substrats EspE, EspF and EspH. De plus, nous avons également prouvé qu’EspL interagissait 
avec EspD, une autre protéine chaperonne stabilisant les protéines substrats EspA et EspC. L’absence d’espL 
chez M. tuberculosis entraine un défaut de croissance de la bactérie, une perte de la cytotoxicité et une 
réduction de la production de cytokines dans les cellules hôtes démontrant le rôle critique de EspL dans la 
virulence de M. tuberculosis. Pour finir, l’analyse de la réponse transcriptionnelle a rélévée que le seul gène 
dérégulé en l’absence de espL est whiB6, codant pour un facteur de régulation qui contrôle les gènes du système 
de sécrétion ESX-1. Par la suite, nous avons démontré que la délétion de WhiB6 chez M. tuberculosis entraine 
une réduction de la cytotoxicité ex vivo.  
En général, nos investigations ont permis d’améliorer notre connaissance du système de sécrétion ESX-1 ainsi 
que les bases moléculaires de la virulence de M. tuberculosis. L’évolution et l’amélioration des connaissances 
 
iv 
des interactions entre le pathogène et l’homme permettront de mettre en place de nouvelles stratégies pour 
contrôler la transmission de la tuberculose. 
Mots-clés: tuberculose (TB), Mycobacterium tuberculosis, virulence, système de sécrétion ESX-1, EccE1, 
EspL, WhiB6. 
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? ?????????????
Human tuberculosis (TB) is a bacterial infectious disease that has plagued humankind for thousands of years. 
Characterized by the formation of tubercles in the lungs, TB is a chronic disease that causes extensive 
morbidity, mortality and loss of wealth. Despite the availability of a vaccine and effective treatment, TB 
continues to spread in every corner of the world. Classified by the World Health Organization (WHO) as the 
top infectious killer worldwide, TB caused over 10.4 million new cases and 1.7 million deaths in 2017 [1]. 
TB is mainly a pulmonary disease but can also affect other tissues. For instance, it can develop in the central 
nervous system, causing meningitis, and in the bloodstream resulting in multiorgan affection. However, the 
lungs are the predominant site of disease manifestation [2]. TB results from infection with the bacillus 
Mycobacterium tuberculosis although other species from the Mycobacterium tuberculosis complex can also 
cause the disease [3]. It is transmitted from person to person through the airways when people suffering from 
pulmonary TB expel airborne droplets containing bacteria. Following initial exposure, the period required to 
develop symptoms can range from a few weeks to a lifetime. In about 5% to 10% of infected individuals, the 
disease will continue to progress soon after infection causing active TB. This rapid evolution typically occurs 
in infants and immunosuppressed individuals. However, in the majority of infected individuals, the immune 
system can arrest the progression of the disease. Nonetheless, incomplete eradication of M. tuberculosis can 
lead to the persistence of the bacilli within the human body for a lifetime causing latent TB infection (LTBI). 
In this case, people do not develop symptoms and cannot spread the disease but can undergo reactivation when 
the immune system is weakened [4].  
An estimated 2 billion people have LTBI and are at risk of reactivation of the disease, creating a remarkable 
resource for future cases of active TB. Human immunodeficiency virus (HIV) infection accelerates reactivation 
in LTBI individuals and drastically increases the risk of developing active TB.  HIV-coinfection represents a 
major driving force in the TB epidemic, especially in Africa which in 2016 accounted for 86% of deaths caused 
by HIV-associated TB [1]. Treatment of these patients has additional difficulties due to the adverse interaction 
between anti-TB and anti-retroviral drugs, making the control of the disease even more complicated. The 
situation in recent years was worsened mainly due to the emergence of multidrug-resistant (MDR) M. 
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tuberculosis strains, which no longer respond to frontline treatment.  4.1% of new and 19% of previously 
treated TB cases in the world are estimated to have MDR -TB [1].  
At the present time, TB is still a global health problem far from being eradicated. The development of 
successful strategies to control the spread of TB will greatly depend on the proper understanding of the 
complex interactions between the pathogen and the human host.  
? ???????? ??????? ???????????????
Known in past times as phthisis, consumption or white plague, TB has always been a permanent challenge 
over the course of human history [5]. Archaeological evidence of TB and mycobacterial DNA has been found 
in Egyptian and South American mummies dating from 3000-5000 years BC. In Ancient Greece, TB was 
already known as a fatal disease. At that time, a well-documented description of the symptoms and tubercular 
lung lesions already existed.  During the 18-19th century TB became epidemic in Europe with a mortality rate 
as high as 900 deaths per 100 000  inhabitants per year [5, 6]. It was not until Dr Robert Koch discovered the 
"Tubercle bacillus" as the causative agent of the disease, that the history of TB started to change. In 1882, 
Koch identified, isolated and cultivated the bacillus and reproduced the disease in laboratory animals [7]. In 
the decades following this discovery, several breakthroughs such as the development of the Bacille Calmette-
Guerin (BCG) vaccine and the introduction of chemotherapy together with the improvement of living 
conditions, allowed to decrease TB burden during the 20th century. More recently, the HIV/ AIDS epidemic 
and the emergence of MDR-TB strains have worsened the situation.  
?????? ??????????
Koch's discovery resulted in the isolation of tuberculin, a glycerin extract of the bacilli. This extract was found 
to produce a skin reaction on infected patients and hence exploited as a diagnostic tool that became the 
tuberculin skin test (TST). TST was later improved by using purified protein derivative (PPD) from sterilised 
M. tuberculosis cultures [6]. Due to its low cost, TST remains widely used albeit it fails to distinguish between 
M. tuberculosis-infected individuals and the BCG vaccinated and therefore, can cause false positive results 
[8]. The identification of potent immunogenic secreted factors in M. tuberculosis resulted in the development 
of the interferon-gamma release assay (IGRA). This TB test is based on the in vitro measurement by ELISA 
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of interferon gamma production by T lymphocytes after stimulation with M. tuberculosis-specific antigens 
(ESAT-6 and CFP10). As these antigens are absent in BCG and most non-tuberculous mycobacteria, IGRA 
test can be used to differentiate between M. tuberculosis infection and prior BCG vaccination [8]. Since 2008, 
the rapid molecular Xpert MTB/RIF test allows the detection of several mycobacterial species and rifampicin-
resistant bacteria in sputum using DNA analysis. It is recommended by the WHO since 2010 and represents 
one of the most sensitive TB tests currently available [9]. However, the most common laboratory test for 
diagnosing TB worldwide is sputum smear analysis, where the presence of mycobacteria in sputum samples 
is examined under a microscope. Overall, the most sensitive method to screen active TB and antibiotic-
resistance is the culture in liquid medium. Microbiological tests are usually combined with a chest X-ray when 
a person is suspected to have active TB.  
?????? ????????????
Based on the attenuation principle of Louis Pasteur, Albert Calmette and Camille Guerin developed, at the 
beginning of the 20th century, the first vaccine against TB named BCG. They sub-cultured the virulent bovine 
strain Mycobacterium bovis during eleven years in a glycerin-bile-potato mixture. During the course of the 
passages, M. bovis lost its virulence as demonstrated when injected into cattle and other animals [10]. Since 
1921, when it was shown to be harmless and protective in humans, BCG has been extensively used as a live 
attenuated strain. Over 90 years, more than 4 billion individuals have been vaccinated with BCG. 
Unfortunately, its efficiency remains controversial. Whereas some studies reported a high protection rate for 
tuberculosis meningitis in children, others have claimed an inconsistent efficacy against pulmonary disease, 
particularly in adolescents and young adults [10, 11]. Additionally, BCG is contraindicated in HIV-infected 
adults as it can disseminate in immunocompromised individuals.  
Today, BCG is the only available vaccine against TB, but a range of new TB vaccine candidates have been 
developed, of which several have reached the clinical trial pipeline. One promising case is the H1/IC31 
vaccine. This subunit vaccine is composed of two immunodominant and specific antigens of M. tuberculosis  
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expressed as a fusion protein: Ag85B (antigen 85b)-ESAT-6 (early secreted antigenic target of 6 kDa, or 
EsxA). To increase protectivity and boost the BCG primed-individuals, H1 is formulated with the adjuvant 
IC3 [12, 13]. Introducing immunodominant antigens has also been chosen in many other vaccine candidates 
as it was found to enhance protection [14].  
?????? ?????????????????????
Three decades after the development of the BCG vaccine, a significant breakthrough in controlling TB came 
with the introduction of chemotherapy. Streptomycin, isolated in 1944 by Waksman and colleagues, was the 
first antibiotic and bactericidal agent effective against M. tuberculosis. Initially, streptomycin caused a 
dramatic reduction in mortality, but it was soon realised that administration of this drug alone resulted in the 
appearance of drug resistance [15]. Although disappointing, this outcome demonstrated that TB is not easily  
Figure 1. TB vaccines in clinical trials. Taken from [14]. TB vaccine candidates are 
classified into therapeutics vaccines (Ruti and Vaccae) and preventive vaccines (the rest 
indicated in the figure). Preventive vaccines come in three generic types: viable whole-
cell vaccines such as MTBVAC (deletion of phoP and fadD26), inactivated whole-cell 
vaccines such as SRL172 (derived from a non-tuberculous Mycobacterium) and subunit 
vaccines (compose of one or more antigens combined with adjuvants). Examples of 
antigens used in subunit vaccines: ESAT-6, Ag85B, Ag85A and PPE family members. 
(Abbreviations: GSK, Glaxo Smith Kline; MPIIB, Max Planck Institute for Infection 
Biology; VPM, Vakzine Projekt Management; SII, Serum Institute India; SSI, Statens 
Serum Institute; McMaster U, McMaster University; TBVI, Tuberculosis 
Vaccine Initiative; UOXF, University of Oxford; RIBSP, Research Institute for 
Biological Safety Problems)[14]. 
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Table. Classification of anti-TB drugs divided into WHO groups A-D for drug resistant tuberculosis and first-line oral drugs 
Standard 
first-line 
therapy 
 Second-line drugs   Third-line drugs 
 Fluoroquinolones 
(group A) 
 
Injectable agents 
(group B) 
 Others  
(group C) 
 
Add-on agents 
(group D) 
Isoniazid  levofloxacin  kanamycin  D-cycloserine  Clofazimine Delamanid 
rifampicin  moxifloxacin  amikacin  ethionamide  imipenem/cilastin Bedaquiline 
ethambutol  gatifloxacin  capreomycin  prothionamide  High-dose isoniazid Linezolid 
pyrazinamide    (streptomycin)  terizodone  meropenem  
  
 
 
 
 p-Aminosalicylic 
acid 
 amoxicillin/clavul
anate  
        clarithromycin  
 
curable by monotherapy. In the following years, several other anti-TB drugs were discovered which paved the 
way for combination therapy. The current tuberculosis treatment was introduced 40 years ago and consists of 
a combination therapy involving isoniazid, rifampicin, pyrazinamide and ethambutol. The treatment requires 
a minimum of 6 months which is divided into two phases: 2 months of the four drugs together followed by 4 
months of isoniazid and rifampicin. This regimen is effective against drug sensitive M. tuberculosis and 
achieves up to 95% cure rate when administered through directly observed therapy (DOT) and follow-up 
support [16]. Most anti-TB medicines have been used for decades, and resistance to them is widespread. 
Treatment of MDR-TB consists of second-line drugs commonly administered for 18 months or longer. The 
regimen is less efficacious, more expensive and more toxic. Ideally, in vitro drug-susceptibility testing (DST) 
of each patient’s isolate should be used to design the appropriate treatment [16].  
Many research efforts are currently focused on increasing the repertory of TB drugs to find more efficient and 
shorter chemotherapy. Development of anti-virulence drugs is a new strategy that is being explored in M. 
tuberculosis. This approach proposes an alternative way to treat TB where, rather than kill bacteria, the 
pathogen’s ability to cause disease is reduced by blocking the secretion of virulence proteins [17]. This strategy 
has several advantages such as the potential harmless impact on the normal microflora and the prevention of 
resistance development. As compounds that block virulence do not affect essential functions, it is thought that 
they do not exert an intense selective pressure for resistance [18]. Thus far, two classes of molecules that inhibit 
the secretion of the major M. tuberculosis virulence factor EsxA have been identified [19]. Although they have 
a different mode of action, both molecules were effective in protecting host cells from M. tuberculosis damage 
[19]. A better understanding of the M. tuberculosis virulence mechanism is critical to enhancing the 
development of more anti-virulence drugs.   
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? ?????????????
TB in humans and animals is caused by a group of bacteria collectively known as the Mycobacterium 
tuberculosis Complex (MTBC). These bacteria are highly related species belonging to the order 
Actinomycetales and genus Mycobacterium. MTBC comprises the obligate human pathogens M. tuberculosis 
and M. africanum as well as several other species mainly affecting wild and domestic mammals such as M. 
bovis (cattle), M. microti (voles), M. pinnipedii (seals) and M. caprae (ovine) [3]. Other major mycobacterial 
pathogens are M. leprae, the causative agent of leprosy, and M. ulcerans, the agent of Buruli ulcer [2].  
?????? ????? ????
Mycobacteria are rod-shaped prokaryotes with a highly GC-rich genome and a complex cell envelope, which 
is characterised by the presence of long fatty acids called mycolic acids. The envelope of mycobacteria consists 
of a regular phospholipid bilayer plasma membrane, a unique lipid-rich cell wall and an outer capsule [2]. 
Because of the high lipid content, mycobacteria are identified using acid-fast staining (Ziehl-Neelsen stain) 
and not with the commonly used Gram-staining. The particular cell wall of mycobacteria is composed of a 
large core complex where mycolic acids are covalently linked to the peptidoglycan-arabinogalactan matrix. 
Additionally, mycolic acids also associate with a diverse set of free lipids, forming a hydrophobic layer of 
extremely low fluidity called the mycomembrane. Surrounding the cell wall, there is a thick capsular layer 
composed of polysaccharides, proteins and glycolipids. This organisation contributes to the exceptional 
thickness of the mycobacterial cell envelope and the formation of a double protective barrier that confers 
impenetrability to polar molecules and certain host defences [20, 21].  
Additionally, all members of the MTBC are also characterised by a slow growth rate with a replication time 
close to 24h. The robust cell envelope, the slow growth rate and the ability to persist in a latent state are 
fundamental characteristics underlying the chronic nature of TB infection [22].  
?????? ?????????????????????????
M. tuberculosis is an intracellular human pathogen with limited ability to survive outside the human body, and 
therefore, it needs to infect human cells to survive and replicate [23]. To initiate the infection in a new host, 
M. tuberculosis must penetrate into the lung alveoli where it is quickly surrounded and phagocytosed by 
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alveolar macrophages [24]. Macrophages play an important role in controlling bacterial infection as they are 
at the crossroads between the innate and the adaptative immune response. To kill bacteria and control infection, 
macrophages use a set of mechanisms including digestion processes. Thus, after phagocytosis by macrophages, 
bacteria-containing phagosomes interact with endosomes and lysosomes, which ultimately leads to the 
destruction of the invading microorganism. M. tuberculosis, however, has the ability to circumvent 
macrophage killing and replicate inside these immune cells. To avoid intracellular destruction, M. tuberculosis 
interferes with the normal maturation process of the phagosome by blocking phagosome-lysosome fusion and 
thereby avoiding the catalytic environment of this intracellular compartment [25]. This blockage is then 
followed by the escape of the pathogen from the phagosomal compartment, an event required for infection 
progression [26]. To this end, M. tuberculosis prevents phagosome acidification and induces phagosomal 
membrane rupture which results in the release of bacteria into the cytosol [26–28]. Escape from the phagosome 
and the presence of bacterial-derived molecules in the cytosol activate innate immune sensors such as cGAS 
and the NLRP3 inflammasome [29–31]. Consequently, a complex immune response is triggered leading to the 
recruitment of immune cells to the site of the infection and eventually to the formation of a compact aggregate 
of cells creating the granuloma. Most of the times, the immune response fails to eliminate the bacilli. It has 
been suggested that M. tuberculosis can exploit the cellular recruitment to proliferate and disseminate [32]. 
Alternatively, when contained within the walled-off granuloma, M. tuberculosis can enter the so-called 
dormant (latent) state and remain quiescent within the infected tissue [33]. 
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? ??????????????????????????????
Bacteria rely on sophisticated nanomachineries to transport proteins across the cell envelope. Many exported 
proteins have essential functions that require an extracytoplasmic location and, therefore, their export pathway 
is critical for bacterial physiology. The general secretory (Sec) pathway is a highly conserved and essential 
system present in all bacteria and used as the primary route for exporting proteins. It has a channel in the 
cytoplasmic membrane through which unfolded proteins, containing an N-terminal signal peptide, are 
transported using ATP hydrolysis [34]. The twin-arginine translocation (Tat) export machinery is another 
essential pathway, but in contrast to the general Sec, it secretes prefolded proteins, and it is not present in all 
bacteria. Proteins directed to the Tat pathway have an N-terminal signal peptide with a pair of arginine residues 
[34].  
Additionally, pathogenic bacteria also possess specialised secretion systems dedicated to the export of effectors 
that interact with the host. In this context, substrates can be displayed on the bacterial cell surface, secreted 
into the extracellular environment or injected directly into a host cell. Released macromolecules through these  
Figure 2. Intracellular cycle of M. tuberculosis. Adapted from [106, 107]. Bacteria are first 
phagocytosed by alveolar macrophages and subsequently enclosed in a phagosomal 
compartment. Then, pathogenic mycobacteria can block the phagosome-lysosome fusion, 
disrupt the membrane and translocate to the cytosol where it can induce a necrotic cell death of 
infected macrophages. Afterwards, M. tuberculosis can infect other surrounding cells and 
spread intracellularly. Depending on the immune system of the host, the infection can progress 
causing active TB or be arrested leading to latent TB. 
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systems include proteins, DNA and small molecules. Historically, secretion systems have been extensively 
studied in Gram-negative bacteria which has led to the identification of several specialised systems designated 
type I-IX (T1SS-T9SS) [35, 36]. Exceptionally, the T7SS, which was first discovered in the pathogen M. 
tuberculosis, is only present in Gram-positive bacteria [21]. These machineries can be divided into two 
categories; those spanning both the inner membrane (IM) and the outer membrane (OM), and those that span 
the OM only. Secretion across the cell envelope can occur either by a one-step or a two-step mechanism. In 
the case of single-step secretion, substrates can be directly translocated from the cytoplasm into the 
extracellular environment or into target cells. This is typically observed in export systems that span both the 
inner and outer membranes (T1SS, T3SS, T4SS, T6SS). When substrates are secreted by two-step process, 
Figure 3. Secretion systems in didermal bacteria. Taken from [35]. Substrates 
secreted by a one-step mechanism are directly translocated from the cytoplasm into the 
extracellular environment or into target cells. Five kind of secretion system has been 
described to use one-step secretion: type I secretion systems (T1SSs), T3SSs, T4SSs, 
T6SSs and T7SSs (ESX-5 shown). T7SSs are mainly found in mycobacteria, Gram 
positive bacteria with a mycomembrane which is indicated separately in this figure. 
Secretion by a two-step mechanism occurs when substrates are first translocated across 
the plasma membrane thought the Sec/Tat systems and subsequently into the 
extracellular milieu. Secretion system using this mechanism are: T2SS, T5SS, T8SS and 
T9SS. 
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they are first translocated through the cytoplasmic membrane by the Sec/Tat systems and subsequently secreted 
into the extracellular milieu (T2SS, T5SS, T8SS, T9SS) [35, 36].   
Although these specialised secretion systems are distinct in structure and function, they all require the presence 
of a membrane channel, and all use ATP as the primary source of energy to drive the active transport of 
effectors. 
?????? ??????????????? ????????????
In M. tuberculosis there are two essential protein export systems that are responsible for the majority of protein 
export: the Sec and the Tat pathway. In addition, M. tuberculosis also possesses five specialised secretion 
systems dedicated to the export of a more limited set of proteins: the ESX systems. The ESX systems are 
named after the first known identified effector, the 6kDa early secretory antigenic target (ESAT-6; also known 
as EsxA) of M. tuberculosis. More recently, ESX systems have also been referred to as Type VII secretion 
systems following the nomenclature of Gram-negative bacteria to emphasise their presence in a diderm cell 
envelope [21]. Although the ESX systems were first discovered in M. tuberculosis, they also exist across 
pathogenic and non-pathogenic mycobacteria, as well as in other genera of the phylum Actinobacteria [37]. 
Their broad presence suggests diversified functions and probably a long evolutionary process that involved 
gene duplication, gene diversification and horizontal gene transfer between chromosomes and plasmids [37–
39]. In mycobacteria, the ESX systems are multi-protein complexes that transport selected substrates through 
the complex cell envelope [21]. The five ESX systems present in M. tuberculosis are sub-categorised into 
ESX-1 to ESX-5. Although they vary in function and the number of genes, they share common characteristics 
such as the presence of a tandem pair of WXG proteins, an ATPase with a FTSK-SpoIIIE motif and several 
proteins with predicted transmembrane domains [39].  
ESX-1, which was the first Type VII system identified, is required for the full virulence of M. tuberculosis 
[40]. Apart from protein secretion, the ESX-1 system is also involved in DNA transfer through conjugation in 
the non-pathogenic M. smegmatis [41]. ESX-5 has also been linked to virulence as the well as cell envelope 
integrity and uptake of nutrients. ESX-5 is the most-recently evolved cluster and is restricted to slow growing 
mycobacterial species. It is dedicated to the export of a large number of PE and PPE proteins, some of which 
are immunogenic and important for virulence [42–44]. The ESX-3 system is involved in physiologic processes 
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and -particularly- in iron and zinc homeostasis. It is conserved among different mycobacterial species and its 
expression is regulated by the availability of iron and zinc [45]. In contrast to ESX-1, ESX-3 and ESX-5, the 
function of ESX-2 and ESX-4 is unknown. So far, genome mutagenesis showed that ESX-2 and ESX-4 are 
not required for in vitro growth or virulence [46, 47]. Of the five ESX systems, the esx-4 locus has the smallest 
number of genes and it is thought to encode the simplest and most ancient ESX system [37, 48].  
?????? ???????????????????????????
Among all ESX secretion systems, ESX-1 is the most well studied apparatus due to its essential role in the 
virulence mechanism of M. tuberculosis. The ESX-1 apparatus is encoded by a multigene cluster that includes 
two WXG secreted effectors (EsxA and EsxB), genes encoding ESX-conserved components (Ecc), ESX 
secretion-associated proteins (Esp) as well as PE and PPE locus-specific proteins and a subtilisin-like protease 
(MycP). Apart from genes localized in the esx-1 cluster, additional genes situated elsewhere on the 
chromosome are required for the function of ESX systems. For instance, the espACD operon that encodes three 
proteins (EspA, EspC, and EspD) is required for proper ESX-1 activity [49, 50]. The importance of the ESX-
1 system for virulence was first shown by comparative genomic studies between the attenuated live vaccine 
M. bovis BCG strain and the virulent H37Rv M. tuberculosis strain. These studies revealed a deletion of ? 9.5 
kb within the esx-1 locus spanning from rv3871 to rv3879. This deleted region is named region of difference 
1 (RD1) and it contains 9 genes including esxA [51]. Reintroduction of the RD1 region into a BCG strain 
showed increased virulence in immunodeficient mice[40]. Consistent with this, deletion of the RD1 region 
from M. tuberculosis attenuated mycobacterial growth ex vivo and in vivo, demonstrating the crucial role of 
RD1 genes and of the ESX-1 secretion system in M. tuberculosis pathogenesis [52, 53, 54].  
Studies on the intracellular cycle of M. tuberculosis demonstrated the critical role of the ESX-1 apparatus 
during macrophage infection. To circumvent macrophage defences, M. tuberculosis induces phagosomal 
rupture and translocates to the cytosol where it can trigger a necrotic cell death in infected macrophages. 
However, this effect is not observed in non-pathogenic mycobacterial species or attenuated M. tuberculosis 
strains as  
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Figure 4. Genetic organisation and model of ESX systems. Taken from [31]. A. The five esx loci 
are characterised by the presence of two esx genes that encode secreted effectors, several ecc genes 
that encode for ESX-conserved components and various locus-specific genes. The spontaneous 
deletion in the esx-1 region present in the M. bovis BCG strain and M. microti are indicated with red 
and blue shading. These deletions are thought to be associated with its attenuated phenotype. B. Model 
of the ESX secretion systems. The membrane proteins EccB, EccC, EccD, EccE and MycP form the 
core structure in the inner membrane. EccC has ATPase domains in the cytoplasm involved in substrate 
recognition and energy production for active secretion. EccA and EspG interact with substrates and 
could potentially execute a chaperone-like activity. Substrates are usually secreted as heterodimers 
(PE/PPE, EsxA/EsxB, EspA/EspC) and some of them are co-dependent for secretion (EsxA/EsxB and 
EspA/EspC). How proteins are transported across the mycomembrane is still unclear. 
B 
A 
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they remain enclosed within the phagosome [55, 56]. Furthermore, complementation of the attenuated strains 
M. tuberculosis ?RD1 or BCG with the ESX-1 secretion system restores the ability to cause phagosomal 
rupture, suggesting that this effect depends on ESX-1 [55, 56]. Hence, the ability to translocate to the cytosol, 
which depends on the ESX-1 secretion system, has been linked to M. tuberculosis cytotoxicity and virulence. 
???????? ?????????????????
The first ESX-1 substrates to be identified were the immunodominant protein antigens, EsxA and EsxB 
(otherwise known as CFP10 (culture filtrate protein of 10KDa)).  Both proteins are encoded within the RD1 
region and their deletion results in similar attenuated phenotypes as a mutant strain deficient for RD1 (?RD1) 
[53, 57]. EsxA induces a potent and highly specific T-cell response in humans and multiple laboratory animal 
species [58–60]. 
EsxA and EsxB are small secreted proteins with an approximate size of ~100 aa characterised by the lack of a 
classical signal sequence and the presence of a conserved Trp-x-Gly (WxG) motif which contributes to the 
formation of a helix-turn-helix structure [61, 62]. They form a 1:1 complex in vitro and are co-secreted in 
mycobacteria; therefore they are thought to be exported as a heterodimer by the ESX-1 apparatus [49, 63, 64]. 
The C-terminal domain of EsxA was shown to be essential for biological functions whereas the C-terminus of 
EsxB, which contains a secretion motif (Trp-XXX-Asp/Glu), was reported to be critical for secretion of both 
proteins [65, 66]. The EsxA/B complex can dissociate in acidic pH conditions, which is an important factor 
inside phagosomes [63, 67]. In such conditions, EsxA and EsxB were showed to interact with biologically 
relevant liposomal preparations suggesting that a similar scenario can occur during host cell infection [67]. 
Several lines of evidence indicate that EsxA can lyse membranes and act as a cytolysin [53, 67, 68], therefore, 
EsxA seems to be the principal candidate for mediating phagosomal escape. Recently, the lytic activity of 
EsxA has been linked to the presence of extractable lipids phthiocerol dimycocerosates (DIM) and membrane 
fluidity. Thus, the presence of DIM was reported to rigidify fluid membranes and decrease the lytic efficiency 
of EsxA [28]. Others, however, have disputed the lytic activity of EsxA and suggested that the ESX-1-mediated 
membrane lysis is contact-dependent and involves gross disruptions [69].  
Aside from the main esx-1 locus, the espACD cluster, which is located more than 260 kb upstream of the esx-
1 locus, is also involved in ESX-1 function. This operon is present in slow-growing and pathogenic 
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mycobacterial species such as M. tuberculosis, M. leprae and M. marinum but absent in non-pathogenic species 
such as M. smegmatis. Although its origin is still unclear, it has been hypothesised that the espACD operon 
was acquired by horizontal gene transfer events that might have contributed to pathogenesis [31]. Interestingly, 
it has a paralogous cluster at the 5’ extremity of the esx-1 locus of M. tuberculosis comprising espEFH. The 
espACD operon encodes three proteins, EspA, EspC and EspD. Importantly, EspA and EspC are co-secreted 
with EsxA and EsxB through the ESX-1 apparatus. Thus, disruption of espA or espC results in abolition of 
EsxA/B secretion and attenuation [49, 50]. EspD, by contrast, is not co-secreted or secreted via ESX-1 although 
its expression but not secretion is required for EsxA and EsxB translocation. Additionally, EspD is also needed 
for stabilizing EspA and EspC levels by an unknown mechanism [70]. The role played by these three ESX-1 
substrates in the virulence mechanism of M. tuberculosis is still under investigations. Besides its implication 
in EsxA and EsxB secretion, EspC has recently been proposed to act as a needle protein, as it polymerises 
upon secretion and forms filaments on the surface of M. tuberculosis [71].  
Another Esp protein and ESX-1 substrate is EspB. This protein contains PE (Pro-Glu) and PPE (Pro-ProGlu) 
domains with helical structure [72]. EspB is expressed as a full-length substrate, but during the secretion 
process, it is cleaved at the C-terminus by the membrane protease MycP1 [73]. In contrast to the full length 
EspB, the processed form of the protein generated during secretion forms oligomers [72]. Secretion of EspB 
was shown to be dependent on EsxA and EsxB expression but independent of EspACD expression [74]. These 
finding demonstrated that EspB could be secreted even though EspA, EspC, EsxA and EsxB are not [74, 75]. 
Although EspB is not co-secreted with EsxA and EsxB, the C-terminus of EspB was shown to be essential for 
secretion of these two Esx substrates as it interacts with and stabilizes EsxA levels [76]. Additionally, EspB 
was reported to bind phospholipids and mediate an EsxA-independent virulence response [74].   
???????? ??????????????????????
The five conserved elements EccB1, EccCa1, EccCb1, EccD1 and EccE1, are putative membrane proteins and 
predicted to be core components of the ESX-1 machinery. Homologues of these proteins that are encoded by  
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the esx-5 locus were shown to form a membrane complex of ~1500 kDa in Mycobacterium bovis, 
Mycobacterium marinum and Mycobacterium xenopi [77–79]. New insight into the structure of the membrane 
complex indicated that the four components Ecc(BCDE)5 are present in equimolar amounts and assemble into 
a hexameric arrangement around a central pore. This membrane complex seems to be embedded exclusively in 
the inner membrane [79]. Considering the conserved nature of the Ecc elements, the presumed structure of the 
ESX-1 membrane complex might resemble that shown for ESX-5. Although the atomic structure of the ESX-
1 complex has not been resolved yet, studying the individual elements has provided significant insights into 
the working mechanism of the machinery.    
??????
EccB1 is an essential component for ESX-1 secretion that is localised in both the membrane and the cell 
wall in M. tuberculosis [80–82]. It contains an N-terminal transmembrane domain and a large C-terminal 
region in the periplasmic space with a hydrophobic core and an elongated shape that shares structural 
similarities to a known peptidoglycan binding protein [82]. These characteristics suggest a role in anchoring 
the ESX-1 system within the periplasmic space [83]. Additionally, EccB1 was reported to have an ATPase 
activity and to probably form hexamers, indicating that it could serve as a transport channel in the 
periplasmic space and use ATP hydrolysis for substrate translocation [82]. However, there is still no 
Figure 5. Reconstruction of the ESX-5 membrane complex. Adapted from [79]. The architecture of 
the ESX-5 membrane complex from Mycobacterium xenopi determined at 13 Å resolution by electron 
microscopy showed that EccB5, EccC5, EccD5 and EccE5 assemble with equimolar stoichiometry into a 
complex with six-fold symmetry [79]. A. Top view of the three-dimensional reconstruction showing a 
central channel with a diameter of ~5nm. B. A side-view cross-section presenting the complex embedded 
in the inner membrane (shadowed grey) and the density of the periplasmic region. The brackets indicate 
the predicted position of EccE5. C. Model of the ESX membrane complex: EccB (B), EccC (C), EccD (D), 
EccE (E). Periplasmic (PP) and cytoplasmic (CP). 
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experimental evidence showing that ATP hydrolysis by this component is related to substrate secretion. 
Furthermore, the structure of EccB1 seems too short to span both the plasma membrane and the 
mycomembrane [82]. If this protein acts as a channel, it may require other components to translocate substrates 
across the cell envelope.    
??????
EccC1 is a member of the FtsK/SpoIIIE-like ATPase family encoded by two operonic genes: eccCa1 and 
eccCb1. Both components interact to form a functional unit with two N-terminal transmembrane domains 
and three ATP-binding sites. Deletion of either eccCa1 or eccCb1 resulted in disruption of ESX-1-related 
secretion and significant attenuation of M. tuberculosis in vivo. Further studies have shown that hydrolysis 
of ATP by EccCa1 and the interaction between EccCb1 and EsxB are critical for ESX-1-related secretion. 
Therefore, EccC1 is likely involved in substrate recognition and may supply energy for protein translocation 
[84–86].  
??????
The gene that codes for the conserved component EccD1 is located within the RD1 region. Several studies 
have shown that it is required for ESX-1-dependent secretion and virulence [40, 81, 86]. EccD1 has an N-
terminal cytoplasmic domain followed by 11 predicted transmembrane helices, and it has been proposed to 
form a cytoplasmic membrane channel. The cytoplasmic region can dimerise creating a negatively charged 
surface, which indicates that it may associate with positively charged elements [83]. Therefore, EccD1 may 
not only form the pore in the cytoplasmic membrane but may also play a role in recruiting other components. 
??????
The functions of EccE components within the secretion apparatus are less clear.  EccE1 is predicted to have 
two N-terminal transmembrane domains and a large C-terminal region in the periplasm, but its biochemical 
characteristics and structure remain unknown. The work of Beckham and colleagues on the structure of the 
ESX-5 membrane complex demonstrated that EccE5 localises at the perimeter of the membrane complex and 
is important for its formation and stability. Additionally, they suggested that the bulk of the protein is in the 
periplasm in agreement with previous bioinformatic predictions.  
Introduction 
 
22 
Interestingly, EccE is the only membrane component that is not present in ESX-4, the most ancestral of the 
ESX systems [37]. This absence may indicate that EccE appeared later in evolution or that it is dispensable to 
form a basic membrane complex. Exceptionally, the esx4 locus of Mycobacterium abscessus, a rapidly growing 
mycobacterium and an opportunistic human pathogen, includes the EccE component. In contrast to M. 
tuberculosis, M. abscessus has a functional ESX-4 system that is required for intracellular survival [87]. This 
data may indicate that the membrane component EccE could be required to assemble a functional ESX system. 
Indeed,  the homologue of EccE1 in M. smegmatis is required for EsxA and EsxB secretion [80] however, 
further information about this component in other mycobacterial species are missing.  
??????
Another conserved component of the ESX-1 apparatus is MycP1, a subtilisin-like protease. MycP1 has a C-
terminal transmembrane domain to anchor the protein in the membrane and direct the protease domain to the 
periplasm [88]. The only known substrate of MycP1 is EspB, which is cleaved at the carboxy terminus region 
after translocation through the inner membrane. Beside its role in substrate processing, MycP1 plays a second 
role by stabilising the ESX-1 membrane complex [78]. In contrast to other membrane and conserved 
components, MycP1 is not part of the core membrane complex although it can loosely associate with it [78]. 
As deletion of the mycP1 gene resulted in disruption of ESX-1-protein secretion, the interaction between MycP1 
and the membrane complex is probably crucial for the integrity and functioning of the machinery [73]. Despite 
the critical role of MycP1 in the secretion process, its protease activity was shown to be dispensable for secretion 
[73, 78]. These observations suggest that processing EspB is not essential for ESX-1 secretion and may serve 
as a regulatory mechanism.  
???????? ?????????????
Elucidating the structure of the ESX-1 apparatus as well as its localization will probably provide us with a 
more comprehensive understanding of its function. Thus far, two studies have addressed the fundamental 
question of ESX localization. The first one used M. marinum KasB-deficient bacteria, which have a permeable 
cell wall, to detect an ESX-1 core component (EccCa1) and a substrate (EspE) by immunofluorescence. Both 
proteins were found at the poles of M. marinum, although the core component was preferentially found in the 
new pole with active peptidoglycan synthesis. Importantly, the polar localization was also confirmed during 
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host cell infection [89]. In line with this finding, a second study found fluorescently tagged proteins required 
for ESX-1 activity (EccCb1 and EspE) at one of the poles of M. smegmatis. However, when the esx-1 locus 
was deleted, the tagged EccCb1 protein did not localise to the cell pole anymore, suggesting the need for other 
ESX-1 proteins for polar assembly [90]. Overall, these studies indicate a polar localisation of ESX-1 
components in two species related to M. tuberculosis.  
???????? ??????????????????
The ESX-1 system is active in in vitro grown cultures, and it is upregulated when mycobacteria infect 
macrophages [91]. This process is regulated by multiple transcriptional regulators such as the two-component 
systems (TCS) PhoPR and MprAB, the nucleoid-associated protein EspR and the redox sensor WhiB6. 
Interestingly, most of the transcriptional effects on ESX-1 converge at the distal espACD operon.  
PhoPR and MprAB respond to environmental signals via sensor kinases (PhoR and MprB) to activate their 
cognate effector proteins which are transcriptional regulatory factors (PhoP and MprA). MprAB is activated 
by cell envelope stress and directly regulates the espACD operon [92, 93]. Inhibition of MprB activity was 
shown to negatively impact ESX-1 secretion and protect host-cells from M. tuberculosis-mediated lysis [19]. 
Consistent with this, deletion of mprAB in M. tuberculosis resulted in aberrant ESX-1 activity [92]. In the case 
of PhoPR, its activation is induced by acidic pH [94], a condition that occurs in maturing phagosomes. 
Mutations in phoP lead to attenuation in vivo in a mouse infection model [95]. Likewise, the point mutation in 
the DNA binding site of PhoP, which is naturally present in the M. tuberculosis H37Ra strain, is responsible 
for the reduced virulence displayed by this strain [96, 97]. PhoP positively regulates many genes within the 
esx-1 locus and also the transcriptional regulator EspR, which in turn binds to several sites upstream of the 
espACD locus to promote its expression [98, 99]. EspR, the ESX-1 secreted protein regulator, was first 
suggested to be an ESX-1 substrate but it was later demonstrated to act as a general nucleoid-associated protein 
that localises to the cytoplasm [100]. It regulates the expression of a wide range of virulence-associated factors, 
and its deletion leads to reduced virulence in macrophages [100, 101]. Another gene that is part of the PhoP 
regulon is whiB6, whose product positively regulates the expression of ESX-1 substrates such as esxA, espA 
or espE. PhoP binds to the promoter region of whiB6 to, generally, promote its expression. Thus, upregulation 
of whiB6 was shown to correlate with increased ESX-1 secretion [102]. Overall, ESX-1 secretion seems to be 
tightly modulated by multiple layers of regulatory mechanisms.  
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? ????????????????????????????
Since the publication of the genome sequence of M. tuberculosis H37Rv in 1998 [39], considerable research 
effort has focused on the identification of factors that contribute to the virulence of this pathogen. In this 
context, mycobacterial genetics and functional genomics have been instrumental in improving our 
understanding of host-pathogen interactions. 
A key finding from the research on mycobacterial pathogenesis and M. bovis BCG attenuation was the 
identification of the ESX-1 secretion system [40, 51, 53]. This specialised apparatus is dedicated to the 
secretion of virulence factors required for intracellular spread and disease progression and represents a 
potential target for novel anti-TB drug discovery [17]. Although the molecular mechanism underlying the 
ESX-1 secretion process is not fully understood, studying individual components has provided valuable 
insights. Genetic approaches and structure-based functional studies have contributed significantly to our 
knowledge about the composition and dynamics of the ESX-1 secretion system. However, we are still far from 
a complete understanding of each of the elements included in the machinery. The objective of the present work 
is to characterise and provide new insights into the functional role of various ESX-1 components in M. 
tuberculosis. To this aim, an integrated approach involving genetics, biochemistry, proteomics and microscopy 
was used.  
Of the five proteins predicted to form the ESX-1 membrane complex (EccB1, EccCa1, EccCb1, EccD1 and 
EccE1), EccE1 is the least investigated especially in M. tuberculosis where no experimental work has been 
reported yet. To improve our knowledge about the membrane apparatus of the ESX-1 secretion system, in 
Chapter 2 we characterised the EccE1 component of M. tuberculosis. For this purpose, we first explored the 
impact of EccE1 on the ESX-1-related activity as well as its localisation in subcellular fractions. As EccE1 was 
found to be a membrane- and cell wall-associated protein critical for ESX-1 function, we tagged EccE1 with a 
fluorescent protein to reveal its localisation and, eventually, that of ESX-1. Our data demonstrate that, in the 
presence of a functional ESX-1 system, EccE1 consistently localises to the poles of M. tuberculosis and suggest 
that the ESX-1 secretion system is located at the polar regions.  
The membrane machinery of ESX-1 is dedicated to the transport of a specific subset of substrates. How these 
substrates are specifically recognised and targeted to the ESX-1 apparatus is not fully understood. Although 
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the general motif YxxxD/E is crucial for the secretion, this motif does not determine system specificity [66]. 
In recent years, it has become clear that dedicated chaperones play a crucial role in the secretion of substrates 
by preventing self-aggregation but also by specifically directing substrates to their respective systems [103]. 
ESX-1 proteins such as EspG1 and EspD were suggested to act as chaperones of ESX-1 substrates [66, 70, 
103]. In addition, EspD was shown to share structural similarity to YbaB, a DNA-binding protein widely-
distributed in bacteria [104]. Interestingly, EspL, an ESX-1 specific protein with an unknown function, also 
has structural similarity to YbaB, suggesting that it can function as a DNA-binding protein or as a chaperone 
[105]. This background knowledge provided a new research direction which led us to investigate the functional 
role of EspL in M. tuberculosis. Chapter 3 describes how we identified EspL as a critical component for ESX-
1 activity and also for the stability of the additional ESX-1 members EspE, EspF and EspH. Furthermore, EspL 
was also found to impact the expression of the transcriptional regulator whiB6. This observation prompted us 
to study this transcriptional activator of ESX-1 genes and demonstrate its essential role in M. tuberculosis-
mediated cytotoxicity as described in Chapter 4. Chapter 5 combines these results in a general conclusion 
and presents future perspectives for this work.  
By studying these ESX-1 components, we contributed to delineating a more comprehensive picture about the 
functioning of the ESX-1 apparatus. Understanding how this secretion system works will help us to 
characterise the molecular basis of M. tuberculosis virulence and obtain deeper knowledge about the complex 
interaction between this pathogen and the human host. This will possibly translate into new preventive and 
pharmacological strategies to fight TB. 
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Mycobacterium tuberculosis is a slow-growing intracellular bacterium with the ability to induce host cell death 
and persist indefinitely in the human body. This pathogen uses the specialised ESX-1 secretion system to 
secrete virulence factors and potent immunogenic effectors required for disease progression. ESX-1 is a multi-
subunit apparatus with a membrane complex that is predicted to form a pore in the cytoplasmic membrane. In 
M. tuberculosis this complex is made of five membrane proteins: EccB1, EccCa1, EccCb1, EccD1, EccE1. In 
this study, we have characterised the membrane component EccE1, and we found that deletion of eccE1 leads 
to disruption of ESX-1 secretion and attenuation of M. tuberculosis ex vivo. Surprisingly, secretion of EspB 
was not affected by loss of EccE1. Furthermore, EccE1 was found to be a membrane- and cell-wall associated 
protein that needs the presence of other ESX-1 components to assemble into a stable complex at the poles of 
M. tuberculosis. Overall, this study provides new insights into the role of EccE1 and its localisation in M. 
tuberculosis.  
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Mycobacterium tuberculosis is a slow-growing intracellular pathogen with the ability to infect and survive 
inside macrophages, the front line of the immune response. Virulence and host-pathogen interaction are 
mediated by protein secretion in the tubercle bacilli [1]. In addition to the general Sec secretory pathway and 
the twin-arginine transporter (TAT) system, M. tuberculosis also encodes five specialised Type VII secretion 
systems (T7SS) which are sub-categorised into ESX-1 to ESX-5 [2].  The T7SS is a multi-subunit apparatus 
dedicated to the transport of selected proteins across the diderm cell envelope. ESX systems share a similar 
structure and secrete related proteins but for different functions [3, 4]. ESX-1 is involved in virulence factor 
secretion and pathogenesis. ESX-3 is critical for bacterial survival due to its function in iron and zinc 
homeostasis. ESX-5 secretes the majority of the PE and PPE proteins, which play an important role in cell wall 
stability and virulence [5]. To date, the functions of the ESX-2 and ESX-4 systems in M. tuberculosis are 
unclear. 
ESX-1 was identified as essential to induce phagosomal rupture thereby allowing translocation to the cytosol 
where bacteria can induce host cell death and subsequently spread to neighbouring cells [6–9]. Deletion or 
inactivation of ESX-1 does not affect growth in vitro but causes attenuation of virulence in infection models 
[10, 11]. Indeed, loss of eight genes (RD1) from the esx-1 locus is the primary attenuating deletion of the live 
tuberculosis vaccine, Mycobacterium bovis BCG [12].  
The locus coding for the ESX-1 secretion system spans 20 genes and codes for secreted factors and structural 
components. Additionally, the distal espACD operon encoding three proteins (EspA, EspC and EspD) is also 
required for proper ESX-1 activity [13, 14].  
The main ESX-1 substrates, EsxA and EsxB,  are two major virulence factors and amongst the most potent T-
cell antigens of M. tuberculosis [4, 15, 16]. Aside from these two substrates, other proteins are also secreted 
through the ESX-1 machinery such as EspB, EspA and EspC. Importantly, EsxA/EsxB and EspA/EspC, but 
not EspB, are co-dependent for secretion [13, 17, 18]. Depletion of any of these proteins leads to severe 
attenuation in cellular and animal models of infection [11, 12, 18–21].  
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ESX-1 has a set of conserved components with homologues in all mycobacterial ESX systems. Thus far, all 
the conserved components are required for the ESX secretion process in at least one mycobacterial species 
[10, 11, 22–28]. The five conserved elements EccB1, EccCa1, EccCb1, EccD1 and EccE1, are putative 
membrane proteins and are considered core components of the ESX-1 machinery. Homologues of these 
proteins encoded by the esx-5 locus form the membrane complex of the ESX-5 secretion system in 
Mycobacterium bovis, Mycobacterium marinum and Mycobacterium xenopi [24, 26, 29]. New insights into 
the structure of the membrane complex indicated that the four components Ecc(BCDE)5 are present in 
equimolar amounts and assemble into an hexameric arrangement around a central pore [29]. Considering the 
conserved nature of the Ecc elements, the presumed structure of the ESX-1 membrane complex might resemble 
that of ESX-5.  
Another conserved component of the ESX-1 apparatus is MycP1, a membrane protein which is not part of the 
core membrane complex but loosely associated with it [26].  MycP1 is a subtilisin-like serine protease that 
cleaves EspB in the periplasmic space [22, 26]. Beside its role in substrate processing, MycP1 plays a second 
role in the secretion process by stabilising the ESX-1 membrane complex [26]. In the esx-1 locus of M. 
tuberculosis, mycP1 is situated upstream of eccE1 and the two genes are co-transcribed [30, 31].  EccE1 is the 
conserved element that has been the least explored, especially in M. tuberculosis where no experimental work 
on this component has been reported yet.  In M. smegmatis, the homologue of EccE1 is required for EsxA and 
EsxB secretion. Previous work on the composition and structure of the ESX-5 membrane complex 
demonstrated that EccE5 is located at the perimeter of the membrane complex and is important for its formation 
and stability [24, 29]. Interestingly, EccE is missing in the ESX-4 apparatus of M. tuberculosis which is the 
most ancestral system. This absence may indicate that EccE appeared later in evolution or that it is dispensable 
to form a basic membrane complex. Indeed, a membrane subcomplex without EccE5 can be constituted in M. 
xenopi. This ESX-5 subcomplex is less abundant, smaller but with similar hexameric assembly as the complete 
membrane complex [29]. Exceptionally, the esx-4 locus of Mycobacterium abscessus, a rapidly growing 
mycobacterium and an opportunistic human pathogen, includes the EccE component. In addition, M. abscessus 
lacks the ESX-1 secretion system and needs the ESX-4 apparatus for intracellular survival [32].    
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Although the molecular mechanisms underlying the ESX secretion process are not fully understood, studying 
individual components has provided important insights. Localizing the active ESX systems can also offer 
valuable information about the mechanism of secretion. ESX-1-related proteins have been visualised at the 
cell poles of M. marinum and M. smegmatis [33, 34]. Nonetheless, information about the localisation of the 
entire ESX-1 system in M. tuberculosis is missing. Considering that Ecc are conserved and core membrane 
components, EccE1 appears as an interesting candidate to localise the active ESX-1 system in M. tuberculosis. 
Moreover, its likely peripheral localisation at the membrane complex is an interesting feature when considering 
the addition of a tag.  
In this study, we explored the role of EccE1 in M. tuberculosis virulence. We showed that EccE1 is required 
for ESX-1-related secretion and ex vivo virulence. Moreover, we investigated the localisation of the protein 
and incorporation into a functional ESX-1 system. Our findings suggest that EccE1 is a membrane- and a cell 
wall-associated protein that requires other ESX-1 components to form a stable complex at the poles of M. 
tuberculosis.  
? ????????
?????????????????????
To assess the role of EccE1 in the ESX-1-related function, we first constructed an eccE1 deletion mutant in M. 
tuberculosis. As eccE1 is in the same transcriptional unit as mycP1 [30, 31], we initially deleted the entire 
mycP1-eccE1 region from the chromosome by allelic exchange. Whole genome sequencing confirmed the 
complete deletion of the mycP1-eccE1 coding sequences (CDS) and the absence of other mutations in the 
genome. The resulting mycP1-eccE1 double mutant was then partially or fully complemented with an 
integrative plasmid encoding either the single genes mycP1 or eccE1, or the entire mycP1-eccE1 locus under the 
control of the PTR promoter. As a result, we obtained four strains: a double mutant ?mycP1-eccE1, a fully 
complemented strain ?mycP1-eccE1/mycP1-eccE1 and two partially complemented strains ?mycP1-
eccE1/mycP1 and ?mycP1-eccE1/eccE1 which correspond to the single mutants ?eccE1 and ?mycP1 
respectively. 
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The four strains were subsequently analysed by RNA sequencing and the transcriptional profile compared to 
that of the H37Rv wild type (WT) strain. As anticipated, no de-regulated genes were found except for the 
deleted genes, suggesting that the excision of eccE1-mycP1 and their complementation in trans did not impact 
the transcription of other genes. In the complemented derivatives, the expression levels of mycP1 and eccE1 
were very similar to those measured in the WT strain (Table S1). 
The ability of the defective strains to grow in synthetic media was explored. The ?eccE1 mutant, as well as the 
?mycP1 and the ?mycP1-eccE1, exhibited growth kinetics similar to that of the WT strain (Figure S1). These 
results indicate that eccE1 and mycP1 are not required for in vitro growth of M. tuberculosis. 
?????????? ?????????????????????????????????????????????????????????????????????????????
Previous studies on the ESX-5 system demonstrated that disruption of this apparatus in M. tuberculosis reduces 
cell wall integrity [23]. Consequently, the susceptibility to various antibiotics targeting several steps in the cell 
wall biosynthetic pathway highly increased [23]. To test whether its paralogue, the ESX-1 system, is also 
involved in maintaining the stability of the cell envelope, the drug susceptibility of the mutants to various cell 
wall targeting antibiotics was evaluated using the resazurin-based microdilution assay (REMA) [35]. The 
?eccE1 mutant and the WT strain were characterised by similar minimal inhibitory concentrations (MIC) to 
all antibiotics tested. The same phenotype was observed for the ?mycP1 and the ?mycP1-eccE1 mutants (Table 
S2). We concluded that the absence of either eccE1 or mycP1 did not impact the susceptibility to ?-lactams 
(penicillins and cephalosporins) or to glycopeptides (vancomycin). These results suggest that loss of the ESX-1 
system does not affect the integrity of the cell envelope in M. tuberculosis. 
?????????? ?????????????????????? ????????????????????????????????????
EccE was identified as a peripheral component of the ESX membrane complex, but further information about 
its role in M. tuberculosis is missing. To investigate the implication of EccE1 in ESX-1-mediated function, we 
exploited the ability of M. tuberculosis to induce host cell death, which is linked to ESX-1-related secretion 
[6, 8]. To this aim, THP-1 human macrophages were infected with the mycP1 and eccE1 mutants as well as 
with the WT strain and the survival of macrophages was monitored. In the presence of WT M. tuberculosis, 
the survival of macrophages significantly decreased compared to the non-infected control. In contrast, when 
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macrophages were infected with strains lacking either eccE1 and/or mycP1, the macrophages survived to levels 
similar to the non-infected control. Importantly, the complemented mutant restored the WT phenotype (Figure 
1A). This result indicates that M. tuberculosis needs both EccE1 and MycP1 for cytotoxicity and that the 
absence of either of these ESX-1 components leads to complete attenuation of M. tuberculosis ex vivo. 
To validate the attenuated phenotype displayed in the absence of eccE1 and/or mycP1, we evaluated the levels 
of intracellular bacteria at 4h, 24h and 72h post-infection by colony forming units (CFU) enumeration. At 4h 
after infection, the bacterial burden was similar for the WT and the mutants, indicating that all strains were 
phagocytosed with similar efficiency (Figure 1B). Once inside the host cell, the ?eccE1, ?mycP1 and the 
?mycP1-eccE1 mutants showed similar and stable CFU numbers over the course of the infection, whereas the 
WT and the complemented mutant exhibited a reduced number of bacteria at 72h post-infection compared to 
previous time points (Figure 1B). The decrease in intracellular bacteria confirmed the ability of the WT strain 
and of the complemented mutant to induce macrophage lysis. Overall, these results demonstrated that M. 
tuberculosis does not require EccE1 or MycP1 to infect or survive inside macrophages, but it needs both 
components to induce host cell death.  
?????? ??? ???????????????????????????????????????????????
To determine if EccE1 and MycP1 are crucial to the function of the ESX-1 machinery, we checked whether the 
deletion of eccE1 and/or mycP1 impacts ESX-protein secretion. To this end, cell lysates and culture filtrates of 
WT and mutant bacteria were prepared and analysed by immunoblotting. The presence of Ag85B, an ESX-1 
independent secreted protein, and the absence of the cytosolic GroEL2 protein from culture filtrates served as 
controls. As expected, EsxA and EsxB were present in the secreted fraction of the WT M. tuberculosis strain. 
However, EsxA and EsxB were not detected in the culture filtrates of the strains lacking eccE1 and/or mycP1 
although both substrates were present in the cell lysates. Furthermore, secretion of EsxA and EsxB was restored 
in the fully complemented strain ?mycP1-eccE1/mycP1-eccE1 (Figure 2A). These data indicate that the presence 
of both MycP1 and EccE1 is required for secretion of the two main ESX-1 substrates. In contrast, EspB, another 
known ESX-1 substrate, was found in the cell lysates and culture filtrates of the WT, mutant and complemented 
strains (Figure 2A), suggesting that secretion of EspB is independent of EccE1 or MycP1. Overall, we can 
conclude that the expression of EsxA, EsxB and EspB is not affected by the absence of EccE1 or MycP1. 
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However, both ESX-1 membrane proteins are essential for EsxA and EsxB secretion but dispensable for the 
release of EspB into the culture filtrate.  
To obtain deeper knowledge into the impact of EccE1 and of MycP1 on M. tuberculosis secretion and to identify 
potential EccE1-dependent substrates, the whole secretome of the mutants was analysed and compared to that 
of the WT strain. Bacteria were grown in the same conditions as previously described for immunoblotting and 
the secreted fraction analysed by mass spectrometry. We found that EsxA, EsxB, EspA and EspC were the 
only proteins significantly deregulated in the culture filtrates (Figure 2B). Moreover, in the WT strain, EsxA 
was in the top ten most abundant proteins. On the other hand, the secretion of this protein decreased by 5-fold 
on average when EccE1 and MycP1 were missing (Figure 2C). The same trend was observed for EsxB, EspA 
and EspC whose secretion was also highly decreased (fold change between 3.6-7.8) in the deletion mutants 
compared to the WT strain (Figure 2C). It was noteworthy that the levels of the rest of ESX-1-related proteins, 
including EspB, was not different in the absence or presence of EccE1 and MycP1. Proteins secreted through 
other secretion systems, such as Ag85B, were secreted at similar levels in the WT and in the mutants (Figure 
2C). Taken together, the secretome analysis demonstrated that only the secretion of EsxA, EsxB, EspA and 
EspC is dependent on EccE1 and MycP1. This analysis also confirmed the previous results obtained by 
immunoblotting. 
??????????? ????????????????? ???????????????????????
As antibodies against EccE1 of M. tuberculosis were not available, an HA tag, which has been successfully 
exploited in the past to study ESX-1-related proteins [36], was inserted in the C-terminal part of EccE1 by 
genetic engineering. For this propose, the double mutant ?mycP1-eccE1 was complemented with an integrative 
plasmid carrying mycP1 and eccE1-HA (?mycP1-eccE1/mycP1-eccE1HA). Both genes were present in single 
copy and expressed under the control of the same promoter, PTR. To make sure that the presence of the tag 
did not interfere with the activity of EccE1, the ability of the HA-tagged mutant to induce cell lysis was tested. 
The THP-1 ex vivo model of infection confirmed that the EccE1-HA expressing mutant was as cytolytic as the 
WT strain, thereby implying the presence of a functional ESX-1 system and so, a functional EccE1 protein 
(Figure 3B).  
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EccE1 is predicted to be a membrane protein in M. tuberculosis. To support this prediction, subcellular 
fractionation followed by immunoblotting was performed using the mutant carrying eccE1-HA. Bacterial 
extracts were separated into cytosolic, membrane, cell wall, capsular and secreted fractions. Several controls 
were employed to validate the procedure. RpoB, an RNA polymerase subunit, was found mainly in the cytosol 
and partly in the membrane. Rv3852, a membrane protein, was only present in the membrane fraction as 
previously described [37]. EsxB, a substrate of the ESX-1 system, was detected in the cytosol and slightly in 
the capsule although it was mainly found in the culture filtrate. Importantly, EsxB was not detected in the 
membrane and the cell wall. Interestingly, EspB, another ESX-1 substrate, was detected everywhere but mainly 
in the cytosol and secreted fractions. Finally, EccE1 was identified in the membrane and cell wall but not in 
other compartments of M. tuberculosis (Figure 3A). 
???????????????? ????????????????????????????????????????? ???????????????
Fluorescent-fusion proteins have been successfully employed to study ESX-1-related proteins in M. smegmatis 
[34]. Overexpression of reporter proteins is usually required for visualisation, however, production of a large 
amount of proteins can eventually lead to artificial phenotypes or artefacts. To avoid this potential problem, 
we constructed a fluorescent-fusion protein of EccE1 with mNeon, a 27 kDa monomeric fluorescent protein 
reported to be three to five times brighter than GFP and export-competent [38–40]. To generate the EccE1-
mNeon expressing strain, the same strategy used for generating the ?eccE1/eccE1-HA was followed. The 
complemented derivative (?mycP1-eccE1/mycP1-eccE1mNeon) has a single copy of mycP1 and eccE1-mNeon 
genes under the control of the PTR promoter, which provides expression of EccE1-mNeon close to 
physiological conditions. To check whether fusion to mNeon impacted EccE1 function, the cytotoxic 
phenotype of the mutant was analysed using THP-1 macrophages. The EccE1-mNeon expressing mutant 
induced cell death similarly to the WT strain (Figure 4B), suggesting that this mutant can form a functional 
ESX-1 secretion system. Since the WT copy of EccE1 is not present in the mutant and this protein is required 
for ESX-1 function in M. tuberculosis, all active ESX-1 apparatuses in the fluorescent mutant should contain 
EccE1-mNeon proteins.  
To gain more insights into the localisation of EccE1 and of the ESX-1 system in M. tuberculosis, the fluorescent 
mutant ?mycP1-eccE1/mycP1-eccE1mNeon was used to image live bacteria. The double mutant ?mycP1-eccE1 
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expressing mNeon alone (?mycP1-eccE1/mNeon) and the H37Rv ??RD1 mutant (lacking most of the esx-1 
locus) expressing EccE1-mNeon (??RD1/mycP1-eccE1mNeon) were used as controls. We observed bi-polar 
foci in 100% of ?mycP1-eccE1/mycP1-eccE1mNeon cells (Figure S2). However, cells expressing mNeon alone 
did not display polar localisation but a diffuse signal all over the bacterium (Figure 4A). Moreover, the ??RD1 
expressing EccE1-mNeon did not show the same bi-polar fluorescent pattern but a more diffuse signal (Figure 
4A). These results indicate that EccE1 localises to the poles of M. tuberculosis and needs others ESX-1-
associated proteins to form a stable complex at the poles of the bacilli. Altogether, we can conclude that the 
bi-polar localisation may not only correspond to the EccE1 protein but also to the functional and assembled 
ESX-1 apparatus.  
? ???????????
Our current knowledge of the ESX secretion systems comes mainly from research on ESX-1 and  
ESX-5. In this context, the role of the membrane protein EccE1 in the secretion process has been so far poorly 
understood. In the present study, we constructed and utilised genetic tools to gain insights into the functional 
role of EccE1 in the virulence mechanism of M. tuberculosis.  
EccE5 was recently described as a peripheral component of the membrane complex important for stabilising 
the machinery [29]. Here, we demonstrated that the absence of EccE1 did not affect M. tuberculosis growth in 
culture medium indicating that this protein is not essential for bacterial survival (Fig. S1). Additionally, EccE1 
was proved to be essential for macrophage lysis, a function required for M. tuberculosis pathogenesis (Fig. 1). 
In line with these observations, previous work reported the inability of the ?RD1 mutant and other ESX-1 
mutants to mediate host cell death and induce full virulence [10, 11, 41]. To the best of our knowledge, this is 
the first time that disruption of the core component EccE1 in M. tuberculosis has been proved to lead to 
complete attenuation ex vivo.  
Analysis of ESX-1-secreted proteins offers a solid explanation for this phenotype. Thus, secretion of EsxA, 
EsxB, EspA and EspC, which is essential to promote virulence [13, 14, 27], was found to be strongly dependent 
on EccE1. This analysis confirmed the critical role of this peripheral membrane protein in the ESX-1 secretion 
process and consequently in the virulence response of M. tuberculosis. Interestingly, EsxA, EsxB, EspA and 
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EspC are known to be co-dependent for secretion, meaning that the absence of one of them completely 
abolishes secretion of the others [13, 14]. Due to this interdependence, we cannot exclude that EccE1 is only 
directly implicated in the secretion of an individual substrate, and consequently, indirectly impacts the 
secretion of other dependent proteins. Similar phenotypes were also observed in the ?mycP1 mutant, 
confirming that MycP1 presence is essential for EsxA/B secretion and virulence in M. tuberculosis as 
previously reported [22].  Surprisingly, secretion of EspB was not affected by the absence of EccE1 and/or 
MycP1 suggesting that secretion of this protein is independent of a fully assembled ESX-1 system. It is 
tempting to hypothesise that EspB might be secreted by a minimal core component before the addition of 
peripheral proteins such as MycP1 and EccE1. Alternatively, an ESX-1-independent secretion mechanism may 
be involved, as postulated for EspD [21]. In contrast with our findings, EspB secretion was previously reported 
to require the presence of MycP1 in both M. tuberculosis and M. marinum [22, 26]. Interestingly, the ESX-2 
secretion system is absent in M. marinum and it may be non-functional in the M. tuberculosis Erdman strain 
as various ESX-2 conserved components are mutated. In the present study, the secretion of EspB was analysed 
in the M. tuberculosis H37Rv strain whereas in previous studies an Erdman background was used [22]. The 
differences in the ESX-2 secretion system may explain the discrepancy of EspB secretion. Thus, EspB might 
be translocated through both the ESX-1 and the ESX-2 secretion systems. However, in the absence of a 
functional ESX-2, EspB secretion may depend exclusively on the ESX-1 apparatus.   
We confirmed that EccE1 is a membrane-anchored protein (Fig. 3). Two potential transmembrane regions in 
the N-terminal part of the protein were identified by the THMM prediction server [42]. However, this region 
is the tip of the iceberg and the C-terminal part of the protein, corresponding to 90% of the protein, is predicted 
to be hydrophilic. The large amount of EccE1 found in the cell wall fraction during our cell fractionation 
experiment strongly suggests that the C-terminus of EccE1 localises in the cell wall. Furthermore, this part of 
the protein is probably malleable and not buried in the complex as the HA and mNeon tags did not interfere 
with EccE1 function. Hence, we hypothesise that EccE1 is a cell wall-associated protein maintained in the 
membrane via a transmembrane anchor. This is consistent with the structure of the ESX-5 membrane complex 
where the soluble domain of EccE5 was predicted to be located in the periplasmic space [29].  
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EccE5 is one of the peripheral proteins of the ESX-5 complex, and consequently, it may be one of the last 
proteins of the core component to associate [24, 29]. Considering the critical role of EccE1 in the secretion of 
EsxA and EsxB in M. tuberculosis (Fig. 2) and its homology with EccE5, we think that EccE1 could be a good 
reporter of a fully assembled and functional ESX-1 secretion system. Two previous studies demonstrated the 
presence of ESX-1 core components at a single cell pole in M. marinum and M. smegmatis using 
immunofluorescence and microscopy analysis of single cells overexpressing fluorescent fusion proteins [33, 
34]. In this study, we localised the fully assembled ESX-1 machinery to both poles of M. tuberculosis using 
non-overexpressed fluorescent EccE1 fusion protein. The fluorescent bipolar foci pattern coming from EccE1-
mNeon was observed in the presence of a functional ESX-1 apparatus, whereas, in the absence of a complete 
esx-1 locus, the EccE1-mNeon signal at the membrane was more diffuse. These observations suggest that the 
polar localisation of EccE1 in M. tuberculosis also corresponds to the fully assembled ESX-1 system. In 
contrast to M. smegmatis and M. marinum, where ESX-1 was preferentially found at a single cell pole, in M. 
tuberculosis 100% of cells displayed bipolar localisation.  
Interestingly, many proteins involved in peptidoglycan, arabinogalactan and mycolic acid biosynthesis also 
localise to polar regions in M. tuberculosis [43, 44]. Previous studies hypothesised that ESX-1 might function 
in the generation or modification of the mycobacterial cell wall [34]. However, we demonstrated that disruption 
of the core components eccE1 and mycP1 and therefore, disruption of the ESX-1 apparatus, did not impact cell 
wall permeability as evidenced by unaltered susceptibility to antibiotics (Table S2). 
Overall, this work has provided new understanding of the ESX-1 system in M. tuberculosis and demonstrated 
that the core component EccE1 is essential for secretion of virulence factors and induction of host cell lysis. 
Moreover, this is the first time that a functional ESX-1 apparatus was localised in M. tuberculosis which could 
be extremely useful for future research aimed to visualise the nanomachine in situ. Investigating how proteins 
are directed to the poles and elucidating the mechanism governing ESX-1 assembly and localisation will 
provide us with important insights to understand this complex virulence determinant.  
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? ?????????????? ???????
Bacterial culture conditions  
M. tuberculosis was routinely grown in 7H9 broth (supplemented with 0.2% glycerol, 10% ADC, 0.05% 
Tween-80) or on 7H10 agar (supplemented with 0.5% glycerol and 10% OADC). Escherichia coli TOP10 or 
chemically-competent E. coli DH5? cells were used for cloning and plasmid propagation and were grown on 
LB broth or agar.  
Mutant construction 
Deletion of the mycP1-eccE1 region was accomplished in the H37Rv strain by two-step homologous 
recombination using the pJG1100-derived vector [45]. To construct the required plasmid, two fragments of 
about 900 bp corresponding to the upstream and downstream regions of mycP1-eccE1, were amplified with 
oligonucleotides MZ-198-F and MZ-199-R and inserted in the pJG1110 vector. After transformation of 
M. tuberculosis H37Rv with the pJG1100-derived vector, the first recombination event was selected on 
Middlebrook 7H10 medium containing hygromycin (50 μg/ml) and kanamycin (20 μg/ml). Positive colonies 
were identified by PCR and subjected to a second round of selection on 7H10 medium supplemented with 
2.5% sucrose. The absence of mycP1-eccE1 in the resulting clones was scored by PCR and further confirmed 
by Southern blotting.  
??????????????????? ???????????????????????
The M. tuberculosis ?mycP1-eccE1 mutant was grown in 10 mL 7H9 broth to OD600 0.8. Bacteria were 
harvested by centrifugation and DNA was extracted using the QIAmp UCP pathogen kit (Qiagen) as 
described previously [46]. DNA was quantified using the Qubit dsDNA HS Assay Kit and the Qubit 2.0 
Fluorometer (Thermo Fisher Sc.). Ilumina libraries were prepared using the Kapa Hyper prep kit as 
described [46]. Briefly, 1?g of extracted DNA was sonicated to obtain 400 bp long fragments with the S220 
Covaris (Covaris) using the manufacturer's protocol and purified using 1.8X AMPure beads (ThermoFisher 
Sc.) and eluted in 50 ?L of Tris-HCl 10mM. Sequencing libraries were synthesised with the Kapa Hyper prep 
kit (Kapa Biosystems) according to the manufacturer’s instructions and an adapter stock of 15 ?M of 
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PentAdaptersTM (PentaBase) was used to barcode the library. After the final amplification step, libraries were 
quantified using Qubit dsDNA BR Assay Kit (Thermo Fisher Sc) and the fragment size was assessed on a 
Fragment Analyzer (Advanced Analytical Technologies). Finally, libraries were multiplexed and sequenced 
as 100 base-long single-end reads on an Illumina HiSeq 2500 instrument. Reads were adapter- and quality-
trimmed with Trimmomatic v0.33 [47] and mapped onto the M. tuberculosis H37Rv reference genome 
(RefSeq NC_000962.3) using Bowtie2 v2.2.5 [48].??
Complemented derivative constructions   
The integrative pGA44 vector [49] was used to construct all complemented derivates. All plasmids used in 
this study are listed in Table S3. Briefly, the genes of interest were PCR amplified from M. tuberculosis H37Rv 
genomic DNA using appropriate oligonucleotides (Table S4). Then, the PCR fragments were cloned in-frame 
under the PTR promoter into the AvrII and PacI sites. All plasmids were checked by Sanger sequencing and 
were further transformed into competent M. tuberculosis ?mycP1-eccE1 cells together with pGA80 [49] which 
provided the integrase. Transformants were selected on 7H10 agar containing streptomycin (20 μg/ml). Note 
that pPS12 was also transformed in the M. tuberculosis ??RD1 mutant. All complemented derivatives used in 
this study are listed in Table S5. 
RNA-seq 
M. tuberculosis strains were grown in 25 ml of Sauton’s medium without detergent to OD600 ? 0.5. Then, 
cultures were harvested by centrifugation and the resulting pellets resuspended in 1 mL TRIzol Reagent 
(ThermoFisher) and stored at -80°C until further processing. Bacteria were disrupted by bead-beating and total 
RNA was isolated as previously described [50]. Two independent cultures for each strain were used for this 
experiment. Total RNA concentration was measured using the Qubit RNA HS Assay Kit Libraries of 
ribosomal-depleted RNA were prepared with 300 ng of fragmented RNA by the Lausanne Genomic 
Technologies Facility, using the Ribo-zero rRNA removal kit for Gram positive bacteria and the Truseq 
Stranded mRNA Library Prep kit reagents (Illumina). Libraries were multiplexed and sequenced on Illuma 
HiSeq 2500 as single-end 100 nt-long reads and data were processed using the Illumina Pipeline Software 
version 1.84. Reads were adapter- and quality-trimmed with Trimmomatic v0.33 [47] and mapped onto the M. 
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tuberculosis H37Rv reference genome (RefSeq NC_000962.3) using Bowtie2 v2.2.5 [48]. Counting reads over 
features was done with featureCounts from the Subread package v1.4.6 [51] and DESeq2 [52] was used to 
infer differentially expressed genes.  
In vitro growth curves 
All strains were diluted to an initial OD600 of 0.05 in Middlebrook 7H9 medium, and the OD600 recorded at 
different time points over a period of 7 days. Data from three independent experiments were used for growth 
representation. 
Antibiotic susceptibility 
To evaluate the susceptibility of bacteria to antibiotics, the MIC values were determined by using the resazurin-
based microdilution assay (REMA) as previously described [35]. M. tuberculosis strains were grown in 7H9 
broth to mid-logarithmic phase (optical density at 600 nm [OD600] of ?0.6) and diluted to an OD600 of 0.0001. 
Then, 3 ? 103 cells/well (100 μl/well) were pipetted into a 96-well plate. Antibiotics (amoxicillin, ampicillin, 
cefadroxil, cefdinir, vancomycin and rifampin) were added to the first column, and subsequently, 2-fold serial 
dilutions were made. Bacteria were incubated in the presence of antibiotics for 6 days at 37°C and afterwards, 
10 μl (1/10 of the total volume) of 0.025% (wt/vol) resazurin were added to each well. The fluorescence 
intensity was read after 16-24 h of incubation at 37°C by using an Infinite F200 Tecan plate reader. MIC values 
were determined by nonlinear fitting of the data to the Gompertz equation [53] using GraphPad Prism. 
Macrophage survival  
Human monocytic THP-1 cells were grown in RPMI medium supplemented with 10% FBS. Monocytes were 
prepared at a concentration of 2x106 cell/ml and differentiated into macrophages using phorbol-12-myristate-
13-acetate (PMA) at a final concentration of 4 nM. Subsequently, 105 cell/well (50 μl/well) were pipetted into 
a 96 well-plate before the plate was sealed with a gas-permeable film and incubated at 37°C with 5% CO2 for 
18h. Medium containing PMA was removed and replaced with 50 μl of new RPMI medium. Bacteria were 
grown to OD600 0.4-0.8, washed, resuspended in 7H9 broth to an OD600 of 1 (3 ? 108 bacteria/ml) and diluted 
in RPMI medium at a concentration of 107 bacteria/ml. THP-1 cells were then infected at a multiplicity of 
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infection (MOI) of 5 (50 μl/well of 107 bacteria/ml in RPMI) and incubated for three days at 37°C with 5% 
CO2. Afterwards, 5 μl (1:20) of PrestoBlue cell viability reagent (Life Technologies) was added to each well, 
the plate incubated for 30 min at 37°C and the fluorescence measured using a Tecan M200 instrument 
(excitation/emission wavelength of 560/590 nm). Fluorescence (560/590) unit of three biological replicates 
(for each strain tested) was analysed in GraphPad Prism (version 5) and significant difference between the 
conditions was determined using the Student t-test. 
Intracellular bacteria  
THP-1 macrophages were infected with M. tuberculosis strains at MOI of 5 as described above. Four hours 
post-infection, extracellular bacteria were removed by washing with warm RPMI medium. Infected 
macrophages were further incubated at 37°C with 5% CO2 in the presence of RPMI.  At 4, 24 and 72h post-
infection, cells were washed twice with warm PBS to remove extracellular bacteria and lysed with 0.1% 
TritonX-100 in PBS. Lysates were diluted, plated on 7H10 medium and the plates were incubated for three 
weeks before the CFU were determined. Results from three independent replicates are represented.  
Protein preparation for secretion analysis 
Bacteria were first grown in 7H9 broth to mid-logarithmic phase (OD600 ? 0.6). Then, bacteria were cultured 
in 30 ml of Sauton's liquid medium supplemented with 0.05% Tween80 at a starting OD600 of 0.1. Cells were 
grown to OD600 of 0.6, centrifuged, resuspended in Sauton's medium without Tween80 and grown further at 
37°C with shaking for 4 days. Cultures were harvested by centrifugation to obtain the cell pellet and the 
secreted fractions. The secreted fraction was filtered through 0.22-μm-pore-size filters to remove M. 
tuberculosis cells and concentrated 100x in Amicon filters with 3-kDa-molecular-weight-cutoff membranes 
(3,000 MWCO) (Millipore). To prepare the cell lysate, the cell pellet was washed once with PBS, resuspended 
in TBS buffer with Roche protease inhibitor cocktail tablets, disrupted by bead beating with 0.1mm zirconia 
beads, clarified by centrifugation and filtered through 0.22-μm-pore-size filters. Total protein concentration in 
all preparations was determined using the BCA assays with bovine serum albumin as the standard.  
 
Immunoblotting 
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Indicated amounts of total proteins from the culture filtrate, total cell lysates and subcellular fractions were 
resolved in NuPAGE 4-12% bis-Tris gels (Invitrogen). Proteins were transferred to nitrocellulose membranes 
using the iBlot gel transfer system (Invitrogen). Membranes were blocked with 5% milk in TBS (150 mM 
NaCl, 20 mM Tris-HCl, pH 7.5 and nonfat milk powder) for 1h and then incubated with the required antibody 
diluted in TBST-1% BSA (TBS, 0.05% Tween-20, BSA) for 16h at 4°C. Membranes were washed with TBST 
3 times before and after being incubated with the appropriate secondary antibody for 30 min at room 
temperature and subsequently developed using a chemiluminescent peroxidase substrate (Sigma-Aldrich). 
GroEL2 was used as a loading control for cell lysates and Ag85B, an ESX-1 independent secreted protein, as 
a loading control for culture filtrate. 
Mass spectrometry-based secretome analysis 
Culture filtrates were incubated 10 min in 100?l of 8 M urea in 0.1 M Tris-HCl pH 8 at room temperature. 
Each sample was digested by Filter Aided Sample Preparation (FASP) [54] with minor modifications. 
Dithiothreitol (DTT) was replaced by Tris(2-carboxyethyl)phosphine (TCEP) as reducing agent and 
Iodoacetamide by Chloracetamide as alkylating agent. A combined proteolytic digestion was performed using 
Endoproteinase Lys-C and Trypsin. Acidified peptides were desalted on C18 StageTips [55] and dried down 
by vacuum centrifugation. For LC MS/MS analysis, peptides were resuspended and separated by reversed-
phase chromatography on a Dionex Ultimate 3000 RSLC nanoUPLC system in-line connected with an 
Orbitrap Q Exactive HF Mass-Spectrometer (Thermo Fischer Scientific). Database search was performed 
using MaxQuant 1.6.0.1 [56] against the TubercuListR27 database (http://tuberculist.epfl.ch/). 
Carbamidomethylation was set as fixed modification, whereas oxidation (M), phosphorylation (S,T,Y) and 
acetylation (Protein N-term) were considered as variable modifications. Label Free Quantification (MaxLFQ) 
was performed by MaxQuant using the standard settings [57]. Perseus [58] was used to highlight differentially 
quantified proteins. Reverse proteins, contaminants and proteins only identified by sites were filtered out. 
Biological replicates were grouped together and protein groups containing a minimum of two LFQ values in 
at least one group were conserved. Empty values were imputed with random numbers from a normal 
distribution. Significant hits were determined by a volcano plot-based strategy, combining t test p-values with 
ratio information [59]. Significance curves in the volcano plot corresponding to a SO value of 0.5 and 0.05 
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FDR were determined by a permutation-based method. Further graphical displays were generated using 
homemade programs written in R [60]. 
Cell fractionation 
The cell fractionation protocol was based on previous work [36, 37]. M. tuberculosis ?eccE1/eccE1HA mutant 
was grown in 100 ml of Sauton’s medium without Tween-80 for 4 days with a starting OD600 0.5. Bacteria 
were harvested by centrifugation and the supernatant concentrated 100 times with Vivaspin columns (3,000 
Da MWCO) after 0.22 μm filtration to obtain the secreted fraction. The cell pellet was washed once with PBS 
and then treated with 0.25% Genapol-X080 for 30 min at room temperature with gentle shaking followed by 
centrifugation at 3,000 g for 10 min. Proteins present in the resulting supernatant were precipitated with 
trichloro-acetic acid (TCA) yielding the capsular fraction [61]. The remaining pellet was washed with PBS 
and subjected to sonication to break the cells. After centrifugation at 3,000 g for 10 min to eliminate unbroken 
cells, the supernatant was centrifuged at 20,000 rpm for 30 min. The resulting pellet, which corresponds to the 
cell wall fraction, was heat inactivated for 1h at 100°C and the supernatant filtered through a 0.22 μm filter 
and centrifuged at 45,000 rpm for 1h in an ultracentrifuge. The supernatant contained the cytosolic fraction, 
while the pellet was enriched with membrane proteins. 
Fluorescence microscopy  
mNeon expressing bacteria were grown in 7H9 broth to log phase (OD600 0.4-0.8). 4 μl of bacterial suspension 
was mounted on a microscope slide with 1.5% agarose pads and directly examined with an Olympus IX81 
microscope under a 100x objective. Images were analysed using ImageJ and normalised for brightness, 
contrast and resolution. 
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Figure 1. EccE1 is required to induce cell death but not for macrophage infection or intracellular survival. 
A. Cell viability of THP-1 human macrophages at 72h post-infection. Uninfected cells were used as a control 
for macrophage survival and the H37Rv wild type strain as a positive control for M. tuberculosis-mediated cell-
death. The ?eccE1, ?mycP1-eccE1 and ?mycP1 mutants did not affect survival of THP-1 macrophages in contrast 
to the complemented strain. 
B. Intracellular bacterial burden at different time points post-infection. The similar number of bacteria at 4h 
post-infection indicates that the ?eccE1, ?mycP1 and ?mycP1-eccE1 mutants infect macrophages with the same 
efficiency as the wild type strain. At 72h post-infection, the decreased number of intracellular bacteria in the 
wild type and the complemented strains correlates with its ability to lyse macrophages. The stable CFU numbers 
observed for ?eccE1, ?mycP1 and ?mycP1-eccE1 over the course of the experiment suggest that these mutants 
can survive inside THP-1 cells. 
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Figure 2. EccE1 is required for ESX-1-dependent secretion. 
A. Immunoblots of culture filtrates (CF, 15 μg per well) and whole cell lysates (CL, 10 μg per well). Detection 
of Ag85B was used as a loading control in the CF and GroEL2 as a loading control in the CL. Secretion of 
EsxA and EsxB but not EspB is disrupted in the ?eccE1, ?mycP1-eccE1, and ?mycP1 mutants. 
B. Proteomic analysis of the secreted fraction showing the difference of the ?mycP1-eccE1 mutant versus the 
wild type strain. The abundance of EsxA, EsxB, EspA and EspC is highly affected in the double mutant 
?mycP1-eccE1 compared to the WT strain. It also demonstrates that EsxA, EsxB, EspA and EspC are the only 
significantly deregulated proteins. The blue dotted line represents the significant curve determined by 
combining T-test values with ratio information and it delineates the differentially quantified proteins. Three 
independent replicates per strain were used for the analysis. 
C. Fold difference (Log2) of secreted proteins present in the WT versus the mutants. EsxA, EsxB, EspA and 
EspC are detected in significantly lower amounts in the culture filtrate of the mutants compared to the WT.  
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Figure 3. EccE1 localizes to the membrane and cell wall fractions of M. tuberculosis. 
A. Subcellular fractionation of the ?eccE1/eccE1HA mutant followed by immunoblotting of each fraction (20 
μg per well). Detection of RpoB represented a control for lysis, EsxB and EspB were controls for secretion 
and Rv3852 for the membrane fraction. Anti-HA antibodies localised EccE1. 
 B. THP-1 macrophage survival at 72h post-infection. ?eccE1/eccE1HA mutant can induce cell-death ex vivo 
indicating the presence of a functional ESX-1 system and therefore that the HA tag at the C-terminus part of 
the protein did not interfere with EccE1 function. Uninfected cells were used as a control for macrophage 
survival, the H37Rv WT strain and the ?mycP1-eccE1 mutant served as positive and negative controls, 
respectively, for M. tuberculosis-mediated cell-death. 
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Figure 4. EccE1-mNeon and the functional ESX-1 system localize to the poles of M. tuberculosis. 
A. EccE1-mNeon expressing cells (?eccE1/eccE1-mNeon) display a fluorescent signal at the poles of the bacilli. 
When mNeon is expressed without EccE1 (?eccE1/mNeon), the fluorescent signal distributes all over the bacterium. 
Expressing EccE1-mNeon in the ??RD1 mutant, which lacks many of the ESX-1 genes, did not result in polar 
localization, showing that EccE1 requires other ESX-1 protein to localize at the poles. 
B. THP-1 survival at 48h post-infection. The ?eccE1/eccE1-mNeon mutant can induce cell-death ex vivo suggesting 
the presence of functional ESX-1 systems and therefore indicating that the addition of mNeon did not interfere with 
EccE1 function. Uninfected cells were used as a control for macrophage survival, the H37Rv WT strain and the 
?mycP1-eccE1 mutant were used as positive and negative controls respectively for M. tuberculosis-mediated cell-
death. 
 
A 
B 
?eccE1/eccE1-mNeon 
?eccE1/mNeon 
??RD1/eccE1-mNeon 
FITC Contrast Merged 
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? ?????????????? ????????
 
 
 
 
 
 
Figure S 1. EccE1 is not required for in vitro growth.  
Growth curves on synthetic medium (7H9 + ADC). The mutants and the wild type strain display 
similar growth rates. 
Figure S 2. EccE1-mNeon M. tuberculosis showed bi-polar foci in all bacilli. 
 A. ?eccE1/eccE1mNeon cells. Representative image of three independent cultures demonstrating 
that 100% of cells expressing EccE1-mNeon displayed a bi-foci fluorescent pattern. 
B. ??RD1/eccE1mNeon cells. Representative image of three independent cultures proving that 
EccE1-mNeon needs other ESX-1 protein to form a stable complex at the poles of the bacilli. 
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Table S 1. Relative mycP1 and eccE1 expression levels by RNA-sequencing. 
 
?mycP1-eccE1 vs H37Rv 
 
complemented vs H37Rv 
Gene name Fold Change padj 
 
Fold Change padj 
mycP1 NA* NA  1.8166 1.12E-09 
eccE1 NA* NA  2.5552 1.76E-81 
Padj: adjusted p-value. NA: not applicable (*no transcripts in this region). 
 
Table S 2. EccE1 is not required for susceptibility to antibiotics targeting the cell wall. 
 Amoxicillin Ampicillin Cefadroxil Cefdinir Vancomycin Rifampicin 
H37Rv (μg/ml) 6.38a 8.32a 2.06 0.83 0.35a 0.00084a 
?mycP1-eccE1 (μg/ml) 7.64a 8.95a 2.14 0.80 0.47a 0.00086a 
?eccE1 (μg/ml) 7.23 6.60 2.21 1.07 0.41 0.00066 
?mycP1 (μg/ml) 7.42 4.97 2.89 0.85 0.51 0.00066 
Average MIC values (μg/ml) obtained from at least two independent experiments. The ?eccE1, ?mycP1 ?mycP1-eccE1 
and the H37Rv wild type strain responded similarly to cell wall targeting antibiotics. (a) three independent experiments.  
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Table S 3. Plasmids used in this study 
 
Plasmid name Description  Reference 
pJG1100 Suicide vector for mutant construction, HygR, KanR, sacB. [45] 
pGA44 Integrative vector at L5 attB site, carrying the TET-PIP OFF 
expression system, StrR. 
[49] 
pGA80  pMV261-derived vector, carrying the L5 int gene for 
expression in trans, lacking oriM, KanR. 
[49] 
pMZ53 pGA44-derived vector carrying mycP1HA under the PTR 
promoter, integrative, StrR. 
In this study 
pMZ45 pGA44-derived vector carrying eccE1HA under the PTR 
promoter, integrative, StrR. 
In this study 
pPS10 pGA44-derived vector carrying mycP1-eccE1 under the 
PTR promoter, integrative, StrR. 
In this study 
pPS11 pGA44-derived vector carrying mycP1-eccE1HA under the 
PTR promoter, integrative, StrR. 
In this study 
pPS12 pGA44-derived vector carrying mycP1-eccE1mNeon under 
the PTR promoter, integrative, StrR. 
In this study 
pPS13 pGA44-derived vector carrying mNeon under the PTR 
promoter, integrative, StrR. 
In this study 
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Table S 4. Oligonucleotides used in this study  
Primer 
name 
Restriction 
site Sequence 5'? 3' Information 
MZ-198-F PacI AGT CAG TTA ATT AAC AGG TAA GAC AAC 
CAC CGC TG 
To clone UP region of 
mycP1-eccE1 in pJG1100 
    
MZ-199-R AvrII AGT CAG CCT AGG CGC CAC CGT GAT CAG 
AAA GAT 
To clone UP region of 
mycP1-eccE1 in pJG1100 
    
MZ-200-F AvrII AGT CAG CCT AGG GAA AGC CGC TAC 
CAG ATG GC 
To clone DOWN region of 
mycP1-eccE1 in pJG1100 
    
MZ-201-R AscI AGT CAG GGC GCG CCG TAC ACC GGG 
AGA ATT TGG TC 
To clone DOWN region of 
mycP1-eccE1 in pJG1100 
    
MZ-165-F AvrII AGT CAG CCT AGG GTG CAC CGT ATC TTT 
CTG ATC ACG GTG GCG CTG GC 
To clone mycP1 in pGA44 
    
MZ-166-R AscI AGT CAG GGC GCG CCT TAG GCG TAG TCC 
GGC ACG TCG TAC GGG TAT CGG CGG CTC 
AGC GCC CGT C 
To clone mycP1 in pGA44 
    
MZ-173-F AvrII AGT CAG CCT AGG ATG AGA AAT CCT TTA 
GGG CTG CGG TTC AGC 
To clone eccE1 in pGA44 
    
MZ-174-R AscI AGT CAG GGC GCG CCT TAG GCG TAG TCC 
GGC ACG TCG TAC GGG TAC TTC GGC AGC 
GCC ATC TGG T 
To clone eccE1 in pGA44 
    
PS-118-R PacI CTATTTAATTAACTACTTCGGCAGCGCCAT
CTGGTAGCGGC 
To clone mycP1-eccE1 in 
pGA44 
    
PS-124-R PacI CTATTTAATTAACTAAGCGTAATCTGGAA
CATCGTATGGGTACTTCGGCAGCGCCATC
TG 
To clone mycP1-eccE1HA 
in pGA44 
    
PS-119-F AvrII ACTACCTAGGCACCGTATCTTTCTGATCAC
GGTGGCGC 
To clone mycP1-eccE1, 
mycP1-eccE1HA, mycP1-
eccEmNeon in pGA44 
    
PS-147-R 
 
CACCATTCCCGAACCTCCCGAACCTCCCTT
CGGCAGCGCCATCTGG 
To clone mycP1-
eccEmNeon in pGA44 
    
PS-148-F 
 
CCG AAG GGA GGT TCG GGA GGT 
TCGGGAATGGTGAGCAAGGGCGAGG 
To clone mycP1-
eccEmNeon in pGA44 
    
PS-149-R PacI CTATTTAATTAATTACTTGTACAGCTCGTC To clone mNeon in pGA44 
    
PS-153-F AvrII ATGCCTAGGATGGTGAGCAAGGGCGAGG
AG 
To clone mNeon in pGA44 
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  Table S 5. Strains used in this study 
 
 
 
 
 
 
 
 
Strain name Description/genotype Plasmid 
?mycP1-eccE1 Deletion of mycP1-eccE1 region  
?eccE1 ?mycP1- eccE1/ mycP1 pMZ53 
?mycP1 ?mycP1- eccE1/ eccE1 pMZ45 
Complemented ?mycP1- eccE1/ mycP1-eccE1 pPS10 
?eccE1/eccE1-HA ?mycP1- eccE1/ mycP1-eccE1HA pPS11 
?eccE1/eccE1-mNeon ?mycP1- eccE1/ mycP1-eccE1mNeon pPS12 
mNeon alone ?mycP1- eccE1/mNeon pPS13 
??RD1/eccE1-mNeon ??RD1/mycP1-eccE1mNeon pPS12 
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? ?????????
The ESX-1, type VII, secretion system represents the major virulence determinant of Mycobacterium 
tuberculosis, one of the most successful intracellular pathogens. Here, by combining genetic and high-
throughput approaches, we show that EspL, a protein of 115 amino acids, is essential for mediating ESX-1-
dependent virulence and for stabilization of EspE, EspF and EspH protein levels. Indeed, an espL knock-out 
mutant was unable to replicate intracellularly, secrete ESX-1 substrates or stimulate innate cytokine 
production. Moreover, proteomic studies detected greatly reduced amounts of EspE, EspF and EspH in the 
espL mutant as compared to the wild type strain, suggesting a role for EspL as a chaperone. The latter 
conclusion was further supported by discovering that EspL interacts with EspD, which was previously 
demonstrated to stabilize the ESX-1 substrates and effector proteins, EspA and EspC. Loss of EspL also leads 
to downregulation in M. tuberculosis of WhiB6, a redox-sensitive transcriptional activator of ESX-1 genes. 
Overall, our data highlight the importance of a so-far overlooked, though conserved, component of the ESX-
1 secretion system and begin to delineate the role played by EspE, EspF and EspH in virulence and host-
pathogen interaction. 
? ?
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? ?????????????
Mycobacterium tuberculosis, the etiological agent of human tuberculosis, is arguably the world’s most 
successful human pathogen. It is estimated that one third of the world’s population is latently infected by the 
bacterium [1], which can survive in a dormant state inside specialized cellular structures in the lung 
parenchyma called granulomas [2,3]. As a consequence of immunodeficiency or co-morbidities, like HIV or 
diabetes [4,5], latent M. tuberculosis can reactivate and establish an acute infectious process which leads to 
the disease. Host-pathogen interaction and disease progression are mediated by various virulence factors 
encoded by the bacterial genome, the most important of them being the ESX-1 or type VII secretion system 
[6]. 
ESX loci are characterized by genes encoding small secreted proteins with a conserved tryptophan-x-glycine 
(WXG) motif and by transmembrane ATPases belonging to the FtsK-SpoIIIE-like family [7,8]. Five ESX 
systems, implicated in different functions, exist in M. tuberculosis [9]. The ESX-1 cluster comprises 
approximately twenty genes and encodes a specialized secretion apparatus, which releases effectors into the 
extracellular milieu. The relevance of the ESX-1 genes in mycobacterial physiology was recognized when 
attenuation of the vaccine strain M. bovis BCG and of the vole bacillus M. microti was associated with their 
partial deletion [10–14]. Since then, the role played by ESX-1 in cytosolic recognition and stimulation of innate 
immunity [15–17], phagosomal rupture and bacterial escape [18,19], intercellular spread and systemic disease 
[20,21] has been the object of numerous studies. Recently, the ESX-1 secretion system has also been 
considered as a potential drug target for the development of anti-virulence drugs [22]. 
Considerable progress has been made in understanding how the system works and is regulated. Electron 
microscopy-based studies showed that the M. xenopi ESX-5 core membrane complex is composed of four 
proteins (EccB5, the ATPase EccC5, the putative channel EccD5, and EccE5) which assemble into an oligomer 
with a six-fold symmetry [23]. However, it is still unknown how the secreted substrates can cross the 
mycobacterial external membrane, or mycomembrane, although the involvement of EspC, encoded by the 
distal espA-espC-espD locus, has been hypothesized in M. tuberculosis [24]. The current model for ESX-1 
activity proposes heterodimeric and co-dependent complexes as the secreted substrates, i.e. EsxA/EsxB and 
EspA/EspC [25,26]. These are targeted to the inner membrane apparatus by a bipartite secretory signal 
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composed of the WXG motif on the first member of the dimer and of a tyrosine-x-x-x-aspartic acid (YxxxD) 
motif on the second [26,27]. ESX-1 function undergoes transcriptional regulation, exerted by EspR [28], Lsr2 
[29], CRP [30], mIHF (manuscript accepted) and MprA [31] on the espA-espC-espD locus. Additional, post-
transcriptional, control of secretion activity is carried out by the serine protease MycP1 through proteolytic 
cleavage of another ESX-1 substrate, EspB [32]. 
Here, we investigate the role of a previously overlooked ESX-1 component, EspL, in M. tuberculosis. We 
demonstrate that it is essential for mycobacterial replication inside macrophages, for eliciting innate cytokine 
production and for stabilizing the protein levels of the additional ESX-1 members EspE, EspF and EspH. 
? ????????
????????????????????????????????? ??????
In order to evaluate the role of EspL in M. tuberculosis virulence and ESX-1-dependent secretion activity, 
construction of an unmarked deletion mutant was planned. The transcriptional profile of the H37Rv genomic 
region that includes espL was carefully considered to avoid polarity on the downstream gene espK. Studies by 
Cortes and colleagues [33] demonstrated the presence of a polycistronic RNA that covers mycP1, eccE1, espB 
and espL, but not espK, which is transcribed independently (S1A Fig). Additionally, sequence inspection 
revealed that the GTG translational start codon of espL overlaps the stop codon of the preceding gene espB. 
The pJG1100-derived suicide vector [34] was then constructed according to this pre-existing information and 
the espL coding sequence (CDS) was deleted from the chromosome by allelic exchange, from coordinate 
4,360,199 to coordinate 4,360,543, thereby leaving the espB stop codon intact (S1B Fig). The resulting strain, 
named ?espL, was validated by colony PCR (data not shown), immunoblot (Fig 1A) and whole genome 
sequencing. The latter technology identified one single nucleotide polymorphism (SNP) in gene rv1403 
(353T>C), which caused substitution of Val118 with Ala, and one SNP in ethA (A to G transition at position 
368) which resulted in replacement of His123 with Arg. No other differences were noted upon comparison 
with the genome sequence of the parental strain, except for the intended deletion. ?espL was transformed with 
the complementing plasmid pGA44-espL, which carries the espL gene under the control of the PTR promoter, 
or with the empty vector pGA44 as a control [35]. Immunoblot experiments proved that expression of EspL 
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was restored in the complemented strain ?espL/pGA-espL, whereas no band was detected in the control 
?espL/pGA44 (Fig 1A). Consistent with these findings, qRT-PCR showed that the espL mRNA was expressed 
at a level similar to that of the wild type when the gene was provided in trans (Fig 1B). Transcriptional analysis 
was extended to include espB, espK and esxA. While espB and esxA mRNA levels were not altered significantly 
by the mutation introduced or by the ectopic expression of espL, the amount of espK transcript was 2.5-3-fold 
higher in the mutant strain (Fig 1B). 
???????????????????????????????????????????????????????????????????
The ?espL mutant did not show any major difference as compared to the wild type strain during in vitro growth 
in standard medium (S2A Fig). However, infection of THP-1 cells demonstrated severe reduction of the 
cytotoxicity of the mutant, which allowed cell survival to a similar extent as upon infection with the ??RD1 
strain, which lacks the extended RD1 region [36] (Fig 2A). Importantly, expression of espL by pGA44 
complemented the phenotype to wild type levels (Fig 2A). These findings were further confirmed by colony 
forming unit (CFU) enumeration. While all of the strains were equally phagocytosed by THP-1 cells (S2B 
Fig), a major increase in the number of intracellular bacteria over one week was reported when H37Rv and the 
complemented strains, but not ?espL, were used for infection (Fig 2B). 
The crucial role played by the ESX-1 secretion system in inducing expression of cytokines of the innate 
immunity pathways was previously illustrated. In particular, EsxA secretion was found to be responsible for 
activating the cytosolic surveillance pathway based on cGAS-dependent sensing of DNA and the 
inflammasome [15–17]. Here, markedly reduced production of the pro-inflammatory cytokine IL-1? (Fig 2C), 
as well as decreased expression of type I interferon gene IFNB1 (Fig 2D), interferon-stimulated gene ISG15 
(Fig 2E), and interleukin gene IL6 (Fig 2F), were noted after THP-1 infection by the ?espL strain. On the 
contrary, H37Rv and the complemented strain ?espL/pGA-espL elicited production of cytokines belonging to 
both the cGAS-STING-type I Interferon (IFN) and inflammasome axes. Overall, these data indicate that EspL 
is a key player in M. tuberculosis virulence, interaction with the immune system and, likely, in ESX-1 
secretion, as explained below.  
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???????????????????????????????????????????????????????
The secretion profile of the mutant was examined in parallel to that of the wild type strain H37Rv and of the 
complemented mutant strains. While the proteins were produced by all of the strains (Fig 3A), EsxA and EsxB 
were not detectable in the secreted fraction by immunoblot when EspL was missing, whereas EspA and EspD 
levels were greatly reduced (Fig 3B). As a consequence of the compromised secretion, accumulation of EsxA 
and EsxB occurred inside ?espL cells (Fig 3A). Interestingly, EspB was found to be released into the culture 
supernatant in the absence of EspL (Fig 3B), confirming that its secretion is not dependent on EsxA, EsxB, 
EspA or EspD, as reported earlier [37]. Therefore, the severe attenuation of ?espL, described above, correlates 
with lack of secretion of the major virulence factor EsxA. 
???????????????????????????????????????????????
To gain insight into EspL function, the localization of the protein in sub-cellular fractions was studied. Total 
extracts from strain H37Rv were separated into cytosolic, membrane and capsular proteins, in addition to 
culture filtrate preparations. Anti-EspL antibodies identified a protein, with the apparent molecular weight of 
EspL, mainly in the cytosol and, to a lesser extent, in the membrane (Fig 4). EspL was undetectable in the 
culture filtrate. Control antibodies against RpoB, Rv3852 and EsxB recognized their cognate antigens in the 
cytosolic/membrane, membrane only or cytosolic/secreted fractions, as expected [38]. EspL could thus exert 
its function in the cytosol or as a membrane-associated protein. 
?????????????????????????????????????????????? ?????
Since PFAM [39] and recent experimental work [40] predicted the presence of an YbaB-type DNA-binding 
domain [41–43] in EspL, we hypothesized that the protein may influence gene expression through binding to 
DNA. The transcriptome of the mutant strain was then analyzed and compared to that of the wild type by 
RNA-seq. Despite the low cut-off value (2-fold change), none of the M. tuberculosis genes was found to be 
deregulated in ?espL, except for whiB6, whose expression level was decreased by 3-fold on average (S1 
Table), and espL itself, which was not detected in the knock-out mutant. Genes belonging to the ESX-1 cluster, 
as well as genes which are part of other ESX loci (ESX-2 to ESX-5) were expressed at similar levels in the 
mutant as compared to the wild type. Curiously, genes that were reported to be included in the WhiB6 regulon 
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in the related species Mycobacterium marinum [44] were not found to be deregulated by RNA-seq in M. 
tuberculosis ?espL (S1 Table). These findings were confirmed independently by qRT-PCR, which also proved 
that re-introduction of espL into the complemented strain was necessary and sufficient to restore espL and 
whiB6 mRNA levels to normal (S3 Fig). Thus, EspL seems to control expression of whiB6 either directly or 
indirectly. 
?????????????????????? ??????????????????????????????????????????????????????????????
???????????????????????????
Intrigued by the discoveries reported earlier, we examined the impact of constitutive expression of whiB6 in 
the ?espL mutant. Levels of whiB6 mRNA were increased by approximately 4-fold in the ?espL strain carrying 
pGA-whiB6, as compared to wild type. All of the tested genes (i.e. espB, esxA, espE, espF, espH and espA), 
which are part of different transcriptional units [33,45], were induced (Fig 5A), therefore indicating that WhiB6 
works as an activator of ESX-1 genes in M. tuberculosis. However, despite the increased expression of 
virulence-related genes, ?espL/pGA-whiB6 displayed the same attenuation as ?espL, ?espL/pGA44 and 
??RD1 (Fig 5B). In other words, the lack of cytotoxicity caused by deletion of espL could not be bypassed by 
ectopic over-expression of whiB6. EspL is therefore essential for M. tuberculosis virulence.  
????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
?????????? ?????? ??????????????????????? ?????? ?????????? ?????????????????????????? ??? ?????? ??????
??????????????????????????????????????????????????????????????????????????????????????????????????? ???
????????????????????????????????????????????????????????????????????????????????????????????? ?????
????????????????????? ??????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????? ??? ?????????????????????? ????????????? ??????????????????? ?? ?????? ???????
????????????????????????????????????????????????????? ????????????????? ??????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????? ?????????????????????????? ?????????????????????????????????
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???????????????????????????????????????????????????????????????????????????????????????????????????
???????? ????????? ?????? ??????? ????? ?????? ????? ???? ????? ?????? ??? ???? ????? ?????????? ????????????
?????????????????????????? ????????????????????????????????
???????????????????????????????????????????? ???? ????? ????????????????????????????????????????
???? ???????????????????????? ???????????????? ??? ??? ???????? ???????? ??????????? ??? ???????????????
?????????????? ??????????????????????????????????????????????????????????????????????????? ????? ????
???????? ??? ?????? ????? ????? ?????? ???????? ???????? ????? ??? ???????????? ????????????????????? ????????
??????????????????????????????????????????? ???????????????????? ?????????????????????????????????????????
?????????????????????????????????????????????????? ?? ???????? ????????????????? ?????????? ?????????????
??????????????????????????????????????????????????????
Further confirmation to these findings was obtained by constructing strains that constitutively expressed HA-
tagged EspE in the H37Rv and ?espL backgrounds. Complementation by espL and expression of whiB6 were 
achieved by using the physiological mycP1 promoter, which represents the natural promoter of espL according 
to Cortes and colleagues [33]. Expression of espE.HA was therefore independent from EspL and from WhiB6 
as it was placed under control of the PTR promoter [35]. The wild type phenotype was restored in strain 
?espL/pGA-espE.HA + espL, as shown in S4A and S4B Fig, thereby confirming that expression of EspE.HA 
did not cause abnormal behavior. In line with what has been described before, expression of whiB6 did not 
complement the lack of virulence in ?espL/pGA-espE.HA + whiB6 (S4B Fig) but did increase the 
transcriptional levels of espE and esxA (S4C Fig), the latter result mirrored by the detection of a strong signal 
for the EsxA protein in Fig 7. Transcription of espE.HA was measured by qRT-PCR and confirmed as 
constitutive, almost identical in all of the strains, independently of the presence or absence of EspL and WhiB6 
(S4A and S4C Fig). However, immunoblot analysis demonstrated that EspE.HA amounts in ?espL/pGA-
espE.HA were dramatically reduced (Fig 7), despite the presence of the espE.HA transcript (S4A Fig). 
Conversely, ?espL/pGA-espE.HA + espL (expression of espL in trans) produced levels of EspE.HA equal to 
those in H37Rv/pGA-espE.HA. Providing whiB6 only (?espL/pGA-espE.HA + whiB6) did not restore the 
phenotype (Fig 7). Therefore, the effects mediated by EspL and WhiB6 were uncoupled here: WhiB6 was 
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proved to act at the transcriptional level, whereas EspL was demonstrated to exert its function post-
transcriptionally, presumably on protein stability. 
Taken together, these results highlight a new role for EspL in stabilizing EspE, EspF and EspH protein 
amounts. 
??????????????? ?????????
To identify EspL interacting partners, strains carrying HA-tagged EspL were made. Expression of N- or C-
terminally tagged EspL in ?espL was verified by immunoblot (S5A Fig) and the ability of the modified proteins 
to complement the attenuation profile was checked (S5B Fig). Total cell extracts of strains ?espL/pGA-
espL.HA and ?espL/pGA-HA.espL were employed in immunoprecipitation experiments using anti-HA 
antibodies. Mass spectrometry analysis of the precipitated material demonstrated that EspD was significantly 
enriched in the pulled-down fractions of ?espL/pGA-HA.espL and of ?espL/pGA-espL.HA, together with 
HA.EspL and EspL.HA (S4 Table). Other proteins were detected but their abundance was not increased in the 
immunoprecipitated samples compared to the Input and to the untagged strains H37Rv and ?espL (S4 Table). 
A second readout, i.e. immunoblot, was exploited to validate these data independently. As shown in Fig 8, 
both EspD and EspL levels were highly enriched upon anti-HA immunoprecipitation in both ?espL/pGA-
HA.espL and ?espL/pGA-espL.HA as compared to the Input control and strain H37Rv. On the other hand, 
RpoB and GroEL2 levels were as expected. To conclude, EspL and EspD may interact directly or be part of a 
multiprotein complex inside M. tuberculosis cells. 
? ???????????
The data presented here demonstrate the essentiality of EspL for ESX-1-dependent virulence and for stabilizing 
the intracellular levels of EspE, EspF and EspH in M. tuberculosis. ESX-1-dependent secretion in ?espL was 
severely compromised, with undetectable levels of EsxA, EsxB, EspA and EspD in the culture filtrates. 
Conversely, secretion of EspB was not affected, confirming previous data generated by our group [37]. In line 
with the secretion profile, virulence and innate cytokine production were compromised when THP-1 cells were 
infected by the espL knock-out strain. In this regard, ?espL behaves like the ESX-1-null mutants ?RD1 [13] 
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and ??RD1 [36], which fail to stimulate the innate immune response [15]. Whether these phenotypic traits are 
directly caused by lack of EspL or are mediated by EspE, EspF or EspH is currently unknown and additional 
research is required. 
Although the mechanistic details of these functions remain unknown, a role for EspL as a chaperone protein 
can be proposed. Indeed, the presence of heterodimeric complexes, where one protein acts as a chaperone for 
the other, is not unusual in the ESX-1 system [24,47]. A direct effect of EspL on transcription of espE, espF 
and espH was ruled out by RNA-seq and further confirmed by qRT-PCR. On the other hand, proteomics 
identified EspE, EspF and EspH as the only proteins whose abundance was highly affected by espL deletion. 
Based on these findings, an interaction between EspL and EspE, EspF and EspH could be hypothesized. 
However, those proteins were not detected by mass-spectrometry and immunoblotting analysis of 
immunoprecipitated material from strains expressing EspL.HA or HA.EspL.  
EspL-mediated stabilization of EspE, EspF and EspH levels might therefore occur by other means. 
Interestingly, compelling evidence was obtained for EspL interacting with EspD, which itself is known to act 
as a stabilizer [48], further suggesting the existence of a “chaperone complex” which contributes to regulating 
ESX-1 activity post-transcriptionally and/or post-translationally. Curiously, while EspD stabilizes EspA and 
EspC [48], EspL performs the same task on EspE, EspF and EspH, whose genes are paralogs of espA-espC-
espD [9], although EspL and EspD are different in size and sequence. 
Another interesting finding was the discovery of whiB6 as the only deregulated gene in the ?espL 
transcriptome. Despite reduced expression of whiB6, no difference in the mRNA levels of the genes belonging 
to the WhiB6 putative regulon [44] was observed. This can be ascribed to the culture conditions used in these 
experiments, as it was reported that WhiB6 senses reducing conditions in M. marinum, and regulates 
transcription accordingly, thanks to its Fe-S cluster [44]. Additionally, the 3-fold deregulation of whiB6 may 
not be mirrored by deregulation of its own regulon. Nonetheless, when WhiB6 was provided in trans, 
expression of most of the ESX-1 substrates or components was increased. Thereby, WhiB6 controls 
transcription of the ESX-1 genetic locus in M. tuberculosis too.  
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A recent report described similar and even more pronounced deregulation of whiB6 and of the WhiB6-
dependent genes in M. marinum lacking eccCb1 [49]. In that case, the existence of a negative feedback loop 
connecting the ESX-1 core complex in the membrane to ESX-1 gene expression was postulated [49]. This is 
consistent with our findings in M. tuberculosis as EspL localizes mainly in the cytosol but also in the membrane 
fraction (Fig 4). Another analogy with the eccCb1 mutant in M. marinum lies in the EspE and EspF protein 
levels, which also seem to be subjected to post-transcriptional control [49]. Of note, we demonstrated that 
virulence cannot be restored in ?espL by expression of WhiB6 in trans.  
Altogether, our data indicate an important role for EspL in M. tuberculosis pathogenesis and encourage further 
investigations into the contributions of EspE, EspF and EspH to virulence and to ESX-1-dependent secretion. 
EspF was previously shown to reduce M. tuberculosis virulence in the mouse model when deleted [36], EspH 
was recently identified as a hypervirulence factor in M. marinum [50] but little is known about the role of 
EspE. Conservation of the genes for espH, espD and espL, in the greatly down-sized genome of M. leprae [51] 
suggests a conserved function and this justifies future investigation. 
? ?????????????? ???????
Bacterial strains and culture conditions 
Mycobacterium tuberculosis strains (described in S5 Table) were grown at 37°C in 7H9 medium (Difco) 
supplemented with 0.2% glycerol, 0.05% Tween 80 and 10% albumin-dextrose-catalase (ADC, Middlebrook) 
or on 7H10 plates supplemented with 0.5% glycerol and 10% oleic acid-albumin-dextrose-catalase (OADC, 
Middlebrook). Sauton’s liquid medium was used for culture filtrate analysis. Streptomycin (20 μg/ml), 
kanamycin (20 μg/ml), hygromycin (50 μg/ml) or 2.5% sucrose were added when necessary. Experiments 
involving M. tuberculosis were performed in a Biosafety Level 3 (BSL3) laboratory, according to the national 
and international guidelines (Authorization number A070027/3). For cloning purposes, One Shot TOP10 
chemically competent Escherichia coli (Invitrogen) were grown in Luria–Bertani (LB) broth or on LB agar 
with hygromycin (200 μg/ml), kanamycin (50 μg/ml) or spectinomycin (25 μg/ml).  
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Reagents, plasmid vectors and oligonucleotides  
????????? ????????? ????? ????????? ????? ??????????????? ??????? ?????????? ???????? ???????????? ????
????????????????????? ????????????????????????????????????????????????????????????????????????????
??????? ???????????????? ??????????????????? ??????????????????????????????????????????????? 
Mutant construction 
One kb up- and downstream regions of the espL gene were PCR-amplified, ligated in-frame with the AvrII site 
and cloned into the PacI and AscI sites of pJG1100 [34], resulting in the suicide vector pJG1100-espL-
UP/DOWN. The complementing plasmid pGA44-espL was constructed by cloning the espL gene into vector 
pGA44 [35], under control of the PTR promoter. Deletion of the full-length espL gene was achieved by 
homologous recombination using plasmid pJG1100-espL-UP/DOWN. After transformation of M. tuberculosis 
H37Rv, the first recombination event was selected on 7H10 plates, supplemented with hygromycin and 
kanamycin. Colonies were screened by colony PCR. Two clones that had undergone homologous 
recombination were grown in liquid 7H9 medium with no antibiotics, in order to promote the second 
recombination event and plasmid excision. Selection of the recombinant clones was performed by plating the 
bacteria on 7H10 plates supplemented with sucrose. The resulting colonies were tested by PCR to confirm 
deletion of espL from its native locus and further validated by whole genome sequencing.. 
In vitro growth curves 
M. tuberculosis strains were grown to mid-logarithmic phase and then diluted to an optical density at 600 nm 
(OD600) of 0.05 in 7H9 medium. OD600 was recorded at different time points to obtain the growth curves. 
Genomic DNA preparation and whole genome sequencing 
M. tuberculosis genomic DNA was extracted as previously described [52]. Libraries were prepared using the 
Kapa LTP Library Prep kit (Kapa Biosystems) according to the manufacturer’s recommendations. Cluster 
generation was performed using the Illumina TruSeq SR Cluster Kit v4 reagents and sequenced on the Illumina 
HiSeq 2500 using TruSeq SBS Kit v4 reagents. Sequencing data were demultiplexed using the bcl2fastq 
Conversion Software (v. 2.20, Illumina, San Diego, California, USA). Raw reads were adapter- and quality-
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trimmed with Trimmomatic v0.33 [53]. The quality settings were “SLIDINGWINDOW:5:15 MINLEN:40”. 
Preprocessed reads were mapped onto the M. tuberculosis H37Rv reference genome sequence (RefSeq 
NC_000962.3) with Bowtie2 v2.2.5 [54]. SNP calling was done using VarScan v2.3.9 [55]. To avoid false-
positive SNP calls the following cutoffs were applied: minimum overall coverage of ten non-duplicated reads, 
minimum of five non-duplicated reads supporting the SNP, mapping quality score >8, base quality score >15, 
and a SNP frequency above 80%. All SNPs were manually checked by visualizing the corresponding read 
alignments. Sequencing data have been deposited to the Sequence Read Archive (SRA) under accession 
number SRP158673. 
RNA preparation, reverse-transcription and quantitative polymerase chain reaction (RT-qPCR) 
??? ????????????? ????????? ????? ?????? ??? ?????? ??? ????????? ?????????? ??? ???????????????? ???????? ?????
?????????????????????? ?????????????????????????????????????????????????????????????????????????? ???
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????? ???????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
????????????? ???? ????? ??? ????????? ????????? ??? ??? ????? ????? ?? μ?? ??? ????? ?????????? ??? ????
???????????????????????????????? ?????????????? ???? ????????? ????? ??? ?????????????????? ?????
???????????????????? ?????? ?????????????????????????????????????????? ????????????????????????????
??????????????????????????? ??????????????????????????  
RNA-seq: library preparation, high-throughput sequencing and analysis 
RNA was extracted from biological duplicates as described above. RNA-seq libraries were prepared from 1 
μg of total RNA. The RNA samples were depleted of r-RNAs with the Illumina Ribo-Zero rRNA Removal 
Kit (Gram-Positive Bacteria) then used to generate sequencing libraries with the Illumina TruSeq Stranded 
mRNA reagents, omitting the polyA selection step (Illumina, San Diego, California, USA). Cluster generation 
was performed with the resulting libraries using the Illumina TruSeq SR Cluster Kit v4 reagents and sequenced 
on the Illumina HiSeq 2500 using TruSeq SBS Kit v4 reagents. Sequencing data were demultiplexed using the 
bcl2fastq Conversion Software (v. 2.20, Illumina, San Diego, California, USA). 
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Reads were processed and mapped to the reference genome sequence as described above. Counting reads over 
features was done with featureCounts [56] from the Subread package v1.4.6. Annotation was taken from 
TubercuList release R27 (https://mycobrowser.epfl.ch/releases). Differential gene expression analysis was 
done using DESeq2 [57]. RNA-seq data have been deposited to the Gene Expression Omnibus (GEO) 
repository under accession number GSE118994. 
Mass spectrometry analysis of total protein extracts 
M. tuberculosis cells, grown to mid-exponential phase in 15 ml cultures, were pelleted by centrifugation, 
washed once in PBS (Phosphate Buffered Saline) supplemented with 0.05% Tween 80 and the pellets stored 
at -80°C until further use. Total lysates were obtained by sonication in lysis buffer (100 mM Tris pH 8, 2% 
SDS, cOmplete mini EDTA free Roche) and boiled at 100°C for 1 h. Proteins were quantified by using the 
Pierce BCA Protein Assay kit and 30 μg were submitted for mass spectrometry analysis.  
Each sample was digested by Filter Aided Sample Preparation (FASP) [58] with minor modifications. 
Dithiothreitol (DTT) was replaced by Tris(2-carboxyethyl)phosphine (TCEP) as reducing agent and 
Iodoacetamide by Chloracetamide as alkylating agent. A combined proteolytic digestion was performed using 
Endoproteinase Lys-C and Trypsin. Acidified peptides were desalted on C18 StageTips [59] and dried down 
by vacuum centrifugation. For LC MS/MS analysis, peptides were resuspended and separated by reversed-
phase chromatography on a Dionex Ultimate 3000 RSLC nanoUPLC system in-line connected with an 
Orbitrap Fusion Lumos Mass-Spectrometer (Thermo Fischer Scientific). Database search was performed using 
MaxQuant 1.6.0.1 [60] against the TubercuListR27 database (http://tuberculist.epfl.ch/). 
Carbamidomethylation was set as fixed modification, whereas oxidation (M), phosphorylation (S,T,Y) and 
acetylation (Protein N-term) were considered as variable modifications. Label Free Quantification (MaxLFQ) 
was performed by MaxQuant using the standard settings [61]. Perseus [62] was used to highlight differentially 
quantified proteins. Reverse proteins, contaminants and proteins only identified by sites were filtered out. 
Biological replicates were grouped together and protein groups containing a minimum of two LFQ values in 
at least one group were conserved. Empty values were imputed with random numbers from a normal 
distribution. Significant hits were determined by a volcano plot-based strategy, combining t test p-values with 
ratio information [63]. Significance curves in the volcano plot corresponding to a SO value of 0.5 and 0.05 
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FDR were determined by a permutation-based method. Further graphical displays were generated using 
homemade programs written in R [64]. 
Immunoblot analysis of bacterial lysates and culture filtrates 
M. tuberculosis cultures were grown in 7H9 to mid-logarithmic phase. The culture medium was then replaced 
by Sauton’s supplemented with 0.05% Tween 80 and growth was continued for 3 d. Finally, bacteria were 
pelleted and resuspended in Sauton’s medium without Tween 80 for collection of the culture filtrates. These 
were filtered through 0.22 μm Steriflip Millipore Express Plus Membranes (Millipore), concentrated 100x 
using Amicon Ultracel-3K centrifugal filters (Millipore), quantified by using the Qubit Fluorometric 
Quantitation device (ThermoFisher) and loaded on SDS-PAGE 12–15% NuPAGE gels (Invitrogen) for 
immunoblot analyses. Bacterial pellets were washed once in Tris-Buffered Saline (TBS, 20 mM Tris-HCl pH 
7.5, 150 mM NaCl) and stored at -80°C until further processing. Cells were sonicated in TBS supplemented 
with a protease inhibitor tablet (cOmplete mini EDTA free, Roche) for 15 min and the protein solution was 
then sterilized by filtration through a 0.22 ?m filter (Pall Life Sciences) to remove residual intact cells. Protein 
samples were quantified using Qubit. Equal amounts of protein preparations (10 μg for cell lysates, 15-20 μg 
for culture filtrates) were loaded on SDS-PAGE 12–15% NuPAGE gels (Invitrogen) and transferred onto 
PVDF membranes using a semidry electrophoresis transfer apparatus (Invitrogen). Membranes were incubated 
in TBS-Tween blocking buffer (25 mM Tris pH 7.5, 150 mM NaCl, 0.05 % Tween 20) with 5% w/v skimmed 
milk powder for 2h at 4°C prior to overnight incubation with primary antibody. Membranes were washed in 
TBS-Tween three times at room temperature, and then incubated with secondary antibody for 3 h before 
washing again. Signals were detected using Chemiluminescent Peroxidase Substrate 1 (Sigma-Aldrich). 
Polyclonal anti-EspL, anti-EspB, anti-EspA [48], anti-EspD [48] antibodies were produced by Dr. Ida 
Rosenkrands (Statens Serum Institut, Copenhagen, Denmark). Monoclonal anti-RpoB antibodies were 
purchased from NeoClone, polyclonal anti-EsxB antibodies from Abcam, monoclonal anti-HA antibodies 
conjugated to Horseradish Peroxidase (HRP) from Cell Signaling. Polyclonal anti-Rv3852 antibodies were 
generated by Eurogentec [38]. The following reagents were obtained through BEI Resources, NIAID, NIH: 
monoclonal anti-Antigen 85, monoclonal anti-GroEL2 and polyclonal anti-EsxA antibodies. 
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Fractionation of total bacterial lysate 
Cell fractions were obtained as described previously [38]. Briefly, M. tuberculosis was grown in Sauton’s 
medium with 0.05% Tween 80 to mid-exponential phase, cells were collected by centrifugation, supernatants 
were filtered through 0.22 μm Steriflip Millipore Express Plus Membranes (Millipore) and concentrated 100x 
using Amicon Ultracel-3K centrifugal filters (Millipore) to obtain the culture filtrate fraction. The pellet was 
treated with 0.25 % Genapol-X080 for 30 min at room temperature, followed by centrifugation at 14,000 g for 
10 min. The proteins in the resulting supernatant were precipitated with Trichloroacetic acid (TCA), yielding 
the capsular fraction. The remaining pellet was subjected to sonication to break the cells, sterilized by filtration 
through a 0.22 ?m filter (Pall Life Sciences) followed by ultra-centrifugation at 45,000 rpm for 1h at 4°C. The 
supernatant contained the cytosolic fraction, while the pellet was enriched with membrane proteins. Analysis 
of the protein fractions was carried out by immunoblot as described above. 
Co-immunoprecipitation experiments 
M. tuberculosis cells in 30 ml cultures were pelleted by centrifugation, washed once in PBS (Phosphate 
Buffered Saline) supplemented with 0.05% Tween 80 and the pellets stored at -80°C until further use. Total 
lysates were obtained by sonication in TBS-T (25 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween 20), followed 
by filtration through 0.22 ?m filters (Pall Life Sciences). Fifty microliters of Monoclonal Anti-HA Agarose 
Antibody beads (Sigma-Aldrich) were incubated with approximately 1 mg of bacterial extract in Spin-X 
centrifuge tubes (Costar) for 4 h at 4°C on an orbital shaker. The resin was washed four times in PBS and the 
immunoprecipitated material was eluted from the beads in PBS-SDS sample buffer (100 mM Tris HCl pH 6.8, 
200 mM dithiothreitol, 4% SDS, 0.2% bromophenol blue, 20% glycerol) during a 5 min incubation at 95°C. 
Immunoprecipitated proteins were analyzed either by mass spectrometry as described [24] or by immunoblot. 
A mock (no antibody) control was run in parallel with agarose beads only. 
Cell cultures and infection with M. tuberculosis strains  
THP-1 cells were cultured in RPMI1640 (Life Technologies) supplemented with 10% (v/v) Fetal Calf Serum 
(Life Technologies) and 1% sodium pyruvate (Life Technologies). Cells were differentiated in 96- or 12-well 
plates by addition of 4 nM phorbol 12-myristate 13-acetate (PMA) for 24 h at 37°C in 5% CO2. Differentiated 
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cells were then infected with M. tuberculosis as follows. Bacteria were grown to exponential phase (OD600 
between 0.4 and 0.8), washed once in 7H9 medium, resuspended in 7H9 to an OD600 of 1, equivalent to 3 x 
108 bacteria/ml. The required volume of bacterial suspension was then added to RPMI1640 for infection of 
human THP-1 cells at the multiplicity of infection (MOI) reported in the text. Plates were sealed with gas-
permeable sealing film and incubated at 37°C under 5% CO2. Intracellular bacteria were released by the 
infected cells by addition of 0.5% Triton-X. The suspension was serially diluted in 7H9 and plated on 7H10 
plates. Colony forming units (CFU) were counted after incubation at 37°C for 4-5 weeks. PrestoBlue Assay 
(Thermofisher) to evaluate cell viability was performed according to the manufacturer’s instructions. 
Fluorescence was measured using a Tecan Infinite M200 microplate reader. 
ELISA assays 
Cell culture supernatants from infections in 96-well plates were removed from infected cells 24 h post-
infection. Supernatants were filtered through NANOSEP centrifugal devices (Pall Life Sciences) and assayed 
for human IL-1? (BD Biosciences) according to the manufacturer’s instructions. 
Quantitative polymerase chain reaction (qPCR) analysis of cytokine expression 
RNA from infected cells in the 12-well format was extracted by using Qiagen RNeasy kit according to the 
manufacturer’s instructions 24 h post-infection and reverse-transcribed using the RevertAid First Strand cDNA 
Synthesis kit (Fermentas). Quantitative PCR analysis was performed on an ABI 7900HT instrument. All gene 
expression data are presented as relative expression to GAPDH. 
Statistical analysis 
Statistical analyses were performed in GraphPad PRISM by one-way or two-way ANOVA followed by 
Tukey’s multiple comparison test 
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Figure 2. Ex vivo phenotype of ?espL mutant. A) Virulence of ?espL mutant compared to H37Rv and 
complemented strain in the THP-1 infection model. ??RD1 carries a deletion of the extended ESX-1 
locus. THP-1 cells were infected at multiplicity of infection (MOI) of 5. Fluorescence measurements 
directly correlate with THP-1 viability. Data were expressed as the mean and standard deviation (SD) of 
four independent replicates. B) Colony forming unit (CFU) evaluation of intracellular bacteria upon THP-
1 infection. THP-1 cells were infected at multiplicity of infection (MOI) of 20:1 (cells:bacteria). Data 
were expressed as the mean and SD of two independent replicates. C), D), E) and F) Cytokine expression 
levels measured upon THP-1 infection with different bacterial strains. IL-1? was detected by ELISA 
assays. IFNB, ISG15 and IL6 were quantified by qRT-PCR. Data were expressed as the mean and SD of 
two independent replicates. NI: not infected control. *, p < 0.05. **, p < 0.005. ***, p < 0.0005. ****, p 
< 0.0001. ns, not significant in one-way ANOVA followed by Tukey’s multiple comparison test. 
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Figure 3. Immunoblot analysis of ?espL mutant. A) Total cell lysates prepared from
the indicated bacterial strains were analyzed by immunoblot. Membranes were probed
for RpoB, which represented the loading control, EspB, Antigen 85 (Ag85), EsxB,
GroEL2, EspA, EspD and EsxA. B) Culture filtrates were analyzed as described for 
the total cell lysates. Arrows indicate non-specific bands detected by the anti-EspB and
anti-EspA antibodies. The experiment was repeated two times. One representative
image is shown. 
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Figure 4. Localization of EspL in subcellular fractions. 
The culture filtrate, capsular, membrane and cytosolic 
fractions were analyzed by immunoblot. Membranes were 
probed for RpoB (cytosolic control), Rv3852 (membrane 
control), EsxB (culture filtrate control) 
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Figure 5. Phenotype obtained upon expression of whiB6 in the ?espL mutant. 
A) qRT-PCR analysis of the expression levels of the indicated genes in different 
strains. Data were obtained from two independent replicates, normalized to the 
housekeeping gene sigA and expressed as relative to H37Rv. *, p < 0.05. ***, p < 
0.0005. ****, p < 0.0001 in two-way ANOVA followed by Tukey’s multiple 
comparison test. B) Virulence of ?espL mutant expressing whiB6 in trans 
compared to H37Rv, ?espL and complemented strain in the THP-1 infection 
model. ??RD1 carries a deletion of the extended ESX-1 locus. THP-1 cells were 
infected at multiplicity of infection (MOI) of 5.  Fluorescence measurements 
directly correlate with THP-1 viability. Data were expressed as the mean and SD 
of four independent replicates. NI: not infected control. ****, p < 0.0001. ns, not 
significant in one-way ANOVA followed by Tukey’s multiple comparison test. 
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Figure 6. Mass spectrometry analysis of protein abundance in the ?espL mutant. Total protein 
extracts were prepared in triplicate and subjected to Mass Spectrometry analysis. Each graph shows the 
abundance of the indicated protein in the three replicates in the various strains. WT: H37Rv. Delta_L: 
?espL. Comp_L: ?espL/espL (complemented strain). Comp_whi: ?espL/whiB6 (strain expressing 
whiB6 in trans). Data are expressed as LFQs (Label Free Quantifications). Samples where EspL and 
WhiB6 could not be detected are labeled as “imputed”. 
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Figure 7. Validation of EspE levels in total cell lysates. 
Total cell lysates prepared from the indicated bacterial 
strains were analyzed by immunoblot. Note that all of the 
strains express HA-tagged EspE ectopically. EspE.HA 
was detected by immunodecoration with anti-HA 
antibodies. The experiment was repeated two times. One 
representative image is shown. 
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Figure 8. Interaction of EspL with EspD. Immunoprecipitation experiments on total protein extracts from the 
indicated strains were performed using anti-HA antibodies. Immunoprecipitated material was analyzed by 
immunoblot for detection of RpoB, GroEL2, EspL and EspD. The mock control was run in parallel without antibodies. 
The experiment was repeated three times. One representative image is shown. 
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Figure S1. Construction of ?espL mutant. A) Schematic 
representation of the H37Rv genomic region that encompasses 
the espL gene. The 5’-ends of the mRNAs detected by Cortes 
and colleagues [8] are indicate by bent arrows. B) Construction 
of the ?espL mutant by allelic exchange. An unmarked deletion 
was introduced into the espL native locus 
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 Figure S2. Phenotypic analysis of ?espL mutant. A) Growth curves obtained by 
measuring the optical density at 600 nm of the different strains grown in 7H9 
medium at 37°C with shaking. B) Uptake of various bacterial strains by THP-1 cells. 
The number of intracellular bacteria was evaluated by CFU 3 h post-infection. Data 
were expressed as the mean and SD of two independent replicates. ??RD1 carries 
a deletion of the extended ESX-1 locus. ns, not significant in one-way ANOVA 
followed by Tukey’s multiple comparison test. 
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Figure S3. Validation of RNA-seq results by qRT-PCR. qRT-PCR analysis was performed on 
total RNA extracted from the indicated strains. Expression levels of the various genes were 
obtained from two independent replicates, normalized to the housekeeping gene sigA and 
expressed as relative to H37Rv. **, p < 0.005. ns, not significant in two-way ANOVA followed 
by Tukey’s multiple comparison test. 
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Figure S3. Expression of EspE.HA in H37Rv and in ?espL mutant. A) qRT-PCR analysis of espL, whiB6, esxA 
and espE gene expression levels in different strains. Data were obtained from two independent replicates, 
normalized to the housekeeping gene sigA and expressed as relative to H37Rv. **, p < 0.005. ***, p < 0.0005. ns, 
not significant in two-way ANOVA followed by Tukey’s multiple comparison test. B) Virulence of ?espL mutant 
expressing whiB6 in trans compared to H37Rv, ?espL and complemented strain in the THP-1 infection model. 
Note that all of the strains, except ??RD1, express espE.HA. ??RD1 carries a deletion of the extended ESX-1 
locus. Fluorescence measurements directly correlate with THP-1 viability. Data were expressed as the mean and 
standard deviation (SD) of four independent replicates. NI: not infected control. ****, p < 0.0001. ns, not significant 
in one-way ANOVA followed by Tukey’s multiple comparison test. C) qRT-PCR analysis of the expression levels 
of the indicated genes in different strains, upon ectopic expression of whiB6. Data were obtained from two 
independent replicates, normalized to the housekeeping gene sigA and expressed as relative to H37Rv. ****, p < 
0.0001. ns, not significant in two-way ANOVA followed by Tukey’s multiple comparison test. 
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Figure S4. Validation of the expression of HA-tagged EspL and virulence analysis. A) Immunoblot showing 
expression of EspL.HA and HA.EspL in total protein extracts from two independent clones (1 and 2) obtained 
upon transformation of ?espL with a plasmid encoding espL.HA or HA.espL, respectively. Protein extract from 
espC::Tn/pMDespACHAD [4] was used as a control. B) Virulence of ?espL mutant complemented by espL.HA or 
by HA.espL compared to H37Rv, ?espL and complemented strain in the THP-1 infection model. ??RD1 carries 
a deletion of the extended ESX-1 locus. Fluorescence measurements directly correlate with THP-1 viability. Data 
were expressed as the mean and standard deviation (SD) of four independent replicates. NI: not infected control. 
****, p < 0.0001. ns, not significant in one-way ANOVA followed by Tukey’s multiple comparison test. 
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TABLES SUPPORTING INFORMATION 
Table S1. Results of RNA-seq experiments (.xlsx) (available upon request). 
Table S2. Results of Mass Spectrometry experiments (.xlsx) (available upon request). 
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? ?????????
The specialised ESX-1 secretion system is regulated by multiple transcriptional regulators such the redox 
sensor WhiB6. A single nucleotide insertion in the promoter region of whiB6 downregulates its expression but 
also the expression of various ESX-1 genes. In consequence, the intracellular levels and secretion of EsxA are 
decreased. This single nucleotide insertion is exclusively found in the H37R strain derivatives, H37Rv and 
H37Ra. To gain a deeper knowledge about the role of WhiB6 in regulating the ESX-1 secretion system, we 
have generated a ?whiB6 mutant by recombineering in M. tuberculosis. The absence of WhiB6 markedly 
decreased the ability of the mutant to induce cell death, suggesting that WhiB6 is required for full virulence in 
M. tuberculosis. 
  
 
Investigation of the transcriptional regulator WhiB6 of Mycobacterium tuberculosis 
 
109 
? ?????????????
In Chapter 3, we demonstrated that deletion of the espL gene results in downregulation of whiB6 expression 
and affects ESX-1 function. To further study this mechanism of regulation, we examined the impact of WhiB6 
on ESX-1 activity.  
As a facultative intracellular pathogen, M. tuberculosis needs to adapt to a variety of environmental stresses. 
To avoid intracellular killing and survive inside the host, M. tuberculosis secretes virulence factors through 
the specialized ESX-1 system. Some ESX-1 substrates are potent immunodominant antigens and their 
secretion needs to be tightly regulated to avoid detrimental effects on bacteria [1]. Although the regulation of 
the ESX-1 system is largely unknown, its secretion activity is controlled by a co-dependent export mechanism 
and also by several transcriptional factors [2]. For instance, the transcriptional regulator WhiB6, a member of 
the WhiB family of redox sensor proteins, can tightly regulate transcription of esxA, esxB, or espE [3]. On the 
M. tuberculosis chromosome, WhiB6 is localized upstream of the ESX-1 cluster and its expression is 
controlled by the master regulator PhoP [4]. Comparison of the genomes of M. tuberculosis laboratory strains 
with those of numerous clinical isolates revealed that the promoter region of whiB6 carries a point mutation 
that is exclusively found in the H37R strain derivatives, H37Rv and H37Ra [5]. This polymorphism consists 
of the insertion of a single G 74 bp upstream of whiB6 start codon, which overlaps the PhoP binding site. The 
extra base alters PhoP binding affinity and leads to downregulation of whiB6 expression, which ultimately 
results in different EsxA levels in H37Rv as compared to other isolates. Importantly, when the H37Rv strain 
is complemented with an episomal copy of whiB6 that does not carry the extra base in the promoter region, 
production and secretion of EsxA is restored to the levels of clinical strains [5].  
The link between WhiB6 and ESX-1 was further studied in the fish pathogen Mycobacterium marinum. In this 
bacterium, disruption of whiB6 resulted in lower mRNA levels of esxA and esxB, reduced ESX-1-protein 
secretion and decreased hemolytic activity compared to the WT strain [3]. Moreover, chromatin 
immunoprecipitation experiments (ChIP) demonstrated that WhiB6 binds to the promoter regions of espA, 
espE, eccA1 and whiB6, providing evidence of autoregulation and direct transcriptional control of ESX-1 
substrates and components [3]. WhiB6 has a redox-sensitive Fe-S cluster which is required to regulate ESX-
1-related genes. When this Fe-S cluster is disrupted by continuous exposure to O2, ESX-1 genes are 
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downregulated [3]. Thereby, this transcriptional regulator was hypothesized to sense redox change in the 
environment and mediate an appropriate transcriptional response to modulate ESX-1 secretion [3]. Recently, 
an additional model was proposed for M. marinum where expression of whiB6 and, therefore, of some ESX-1 
genes, is controlled by the presence of the ESX-1 membrane complex [6]. WhiB6 may also sense the presence 
of the secretory machinery and consequently regulate ESX-1 gene expression. 
? ????????
????????????????????
To study the role of WhiB6 on ESX-1 secretion, we tried to generate whiB6 mutants in M. tuberculosis by 
recombineering [7]. Inspired by the work of Solans and colleagues [5], we first planned to remove the point 
mutation that is naturally present in the whiB6 promoter of H37Rv and absent in most of the other M. 
tuberculosis strains. This extra base leads to downregulation of whiB6 expression and eventually lower EsxA 
levels [5]. To prove that the mutation in the promoter region is the primary cause of whiB6 downregulation, 
we also sought to introduce the extra nucleotide in the M. tuberculosis Erdman strain. To obtain these 
modifications in the chromosome, we designed a pair of oligonucleotides (Table 1) and followed the 
recombineering procedure as described in Material and Methods. Despite several attempts, this approach was 
unsuccessful probably due to the highly stable hairpin structures found in these oligonucleotides (Table 1). 
These secondary structures may also occur in the promoter region of whiB6 in both H37Rv and Erdman, thus 
making recombination complicated and infrequent. As an alternative strategy, we designed whiB6 null mutants 
by introducing two stop codons at the beginning of the whiB6 coding sequence (CDS). In this case, the 
oligonucleotide does not form stable hairpin structures (Table 1). One of the challenges faced in this approach 
was the selection of clones that underwent homologous recombination. Modifying whiB6 does not result in an 
easily detectable phenotype such as drug resistance or morphological changes. Therefore, PCR screening 
followed by Sanger sequencing was used to identify positive recombinants. Of the 34 colonies screened, only 
one carried the desired mutations (efficiency of recombination 2.9%). This mutant was further validated by 
whole-genome sequencing which confirmed the presence of two stop codons at the beginning of whiB6 CDS 
and the absence of additional mutations in the genome. The resulting mutant, named ?whiB6, was 
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complemented with an integrative plasmid carrying whiB6 bearing an HA tag coding sequence at the 3’-end. 
This complemented derivative has a copy of whiB6 expressed under the control of a constitutive promoter. 
Transformation with the empty vector was also performed as a control.  
?????????????????????? ?????????????????????????????????????????
M. tuberculosis requires a functional ESX-1 system to mediate host-cell death and survive inside the host [8]. 
To investigate the impact of WhiB6 on ESX-1 function, we analysed the ability of the mutant to induce cell 
lysis in cultured macrophages. THP-1 human cells were infected with the wild type (WT), the ?whiB6 mutant 
and the complemented HA variant and, after three days, macrophage survival was evaluated. In the presence 
of the WT strain, THP-1 survival was drastically reduced compared to uninfected cells. However, when 
macrophages were infected with the ?whiB6 mutant, the THP-1 survival level was substantially higher, 
indicating that this mutant has an impaired cytolytic activity. In contrast, when the ?whiB6 mutant is 
complemented with whiB6-HA, cell survival was significantly compromised and close to that observed with 
the WT (Fig. 1). To exclude the possibility of a negative impact on macrophage survival due to the presence 
of the integrative plasmid, the ?whiB6 mutant transformed with an empty vector was also tested. This strain 
displayed a similar phenotype to the ?whiB6 mutant (Fig. 1) demonstrating that the plasmid used for 
complementation did not affect macrophage viability. Overall, these data suggest that whiB6 is needed to 
mediate macrophage cell lysis and underline the critical role of this transcription factor in the virulence 
response of M. tuberculosis ex vivo.  
? ???????????
ESX-1 secretion is controlled by several mechanisms including transcriptional regulation. To gain deeper 
knowledge into the role played by WhiB6, we generated a ?whiB6 knockout mutant in M. tuberculosis. During 
the construction of the mutant, we realized that the promoter of whiB6 is not an amenable region to introduce 
point mutations probably due to the presence of highly stable stem-loops. The presence of these structures 
might interfere with recombination events explaining why we could only obtain a chromosomal modification 
in the whiB6 CDS. 
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?whiB6 showed impaired ability to cause cell lysis compared to the WT or to the complemented strain. This 
attenuated phenotype was also observed with the mutant carrying the empty vector used for complementation. 
As M. tuberculosis-mediated cytolysis depends on a functional ESX-1 system, it is plausible that EsxA and 
other ESX-1-related proteins are not secreted in the absence of WhiB6. This assumption agrees with previous 
observations in M. marinum where reduced levels of ESX-1 secretion and hemolytic activity were observed 
when the whiB6 gene was disrupted [3]. Interestingly, complementation of the mutant with a single copy of 
whiB6 induced a stronger cytolytic response compared to the WT. This effect may be due to the constitutive 
expression of whiB6 by the PTR promoter, which provides higher levels of mRNA compared to the H37Rv 
strain (results in Chapter 3). Consequently, it is likely that ESX-1 genes regulated by WhiB6 are upregulated 
as well as ESX-1 secretion activity. Although no experimental evidence on gene expression and protein 
secretion are provided here, a similar outcome was observed when H37Rv was transformed with a copy of 
whiB6 from a clinical isolate [5]. In that case, whiB6 was upregulated in H37Rv and bacteria produced and 
secreted larger amounts of EsxA [5]. The cytolytic phenotype displayed by the whiB6-HA complemented 
mutant also indicates that the addition of the HA tag at the C-terminal part of the protein did not interfere with 
WhiB6 activity. The presence of this tag in a functional mutant can be useful for future research aimed to study 
the binding region of WhiB6 by ChIP or protein interactions by immunoprecipitation.   
A link between ESX-1 components and whiB6 expression has been previously studied [6]. Depletion of 
EccCb1 in M. marinum was found to strongly downregulate whiB6 expression. In the same direction, we also 
demonstrated that deletion of espL resulted in downregulation of whiB6 (Chapter 3). These observations 
suggest that ESX-1 could be regulated by a feedback control mechanism where the presence of ESX-1 
components in the bacterial membrane may regulate expression of ESX-1 related genes through WhiB6. In 
contrast to this hypothesis, deletion of the core components eccE1 and mycP1 did not impact whiB6 expression 
or any ESX-1 genes (Chapter 2). As EccCb1 and EspL were shown to interact with and stabilise ESX-1 
substrates [9], it is likely that WhiB6 may need to interact with specific ESX-1 proteins or even with the ESX-
1 complex to mediate a transcriptional response and therefore regulate ESX-1 secretion.   
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Bacterial cultures 
M. tuberculosis was routinely grown in 7H9 broth (supplemented with 0.2% glycerol, 10% ADC, 0.05% 
Tween-80) or on 7H10 agar (supplemented with 0.5% glycerol and 10% OADC). Escherichia coli TOP10 or 
chemically-competent E. coli DH5? cells were used for cloning and plasmid propagation and were grown on 
LB broth or agar.  
Mutant construction by recombineering 
Generation of point mutations in M. tuberculosis H37Rv was done by a recombineering method [10, 11]. First, 
a 70-mer oligonucleotide corresponding to the lagging strand was designed with the mutation in the middle of 
the sequence (Table 1). Then, H37Rv transformed with pJV53, a plasmid that codes for a mycobacterial phage 
recombination system (Che9 RecET), was grown to log phase (OD600 of 0.8) in 7H9 medium containing 
kanamycin (20 μg/ml). Subsequently, the recombination system encoded by pJV53 was induced with 0.2% 
acetamide for 8h before addition of 0.2 M glycine. Bacteria were incubated for additional 16h and then 
collected to prepare competent cells. 500 ng of 70-bp single-stranded oligonucleotide containing the desired 
mutation was transformed by electroporation with plasmid pYUB412 (0.1μg) [12] which was used for counter-
selection. After incubation for 3 days, transformants were selected on 7H10 agar plates containing hygromycin 
(50 μg/ml). PCR followed by Sanger sequencing were used to identify the presence of single-nucleotide 
polymorphisms (SNPs) in the chromosome. 
DNA extraction and whole-genome sequencing 
The M. tuberculosis ?mycP1-eccE1 mutant was grown in 10 mL 7H9 broth to OD600 0.8. Bacteria were 
harvested by centrifugation and DNA was extracted using the QIAmp UCP pathogen kit (Qiagen) as 
described previously [13]. DNA was quantified using the Qubit dsDNA HS Assay Kit and the Qubit 2.0 
Fluorometer (Thermo Fisher Sc.). Ilumina libraries were prepared using the Kapa Hyper prep kit as 
described [13]. Briefly, 1 ?g of extracted DNA was sonicated to obtain 400 bp long fragments with the S220 
Covaris (Covaris) using the manufacturer's protocol and purified using 1.8X AMPure beads 
 
Investigation of the transcriptional regulator WhiB6 of Mycobacterium tuberculosis 
 
114 
(ThermoFisher Sc.) and eluted in 50 ?L of Tris-HCl 10mM. Sequencing libraries were synthesised with the 
Kapa Hyper prep kit (Kapa Biosystems) according to the manufacturer’s instructions and an adapter stock of 
15 ?M of PentAdaptersTM (PentaBase) was used to barcode the library. After the final amplification step, 
libraries were quantified using Qubit dsDNA BR Assay Kit (Thermo Fisher Sc) and the fragment size was 
assessed on a Fragment Analyzer (Advanced Analytical Technologies). Finally, libraries were multiplexed and 
sequenced as 100 base-long single-end reads on an Illumina HiSeq 2500 instrument. Reads were adapter- and 
quality-trimmed with Trimmomatic v0.33 [14] and mapped onto the M. tuberculosis H37Rv reference genome 
(RefSeq NC_000962.3) using Bowtie2 v2.2.5 [15]. 
 Complemented derivative constructions   
The integrative pGA44 vector [16] was used to construct the whiB6-HA complemented derivative. The whiB6 
CDS was PCR amplified from M. tuberculosis H37Rv genomic DNA using oligonucleotides PS-135 and PS-
136 (Table 1). The PCR fragments were cloned in-frame under the control of the PTR promoter, into the AvrII 
and PacI sites. The plasmid was checked by Sanger sequencing and was transformed into competent M. 
tuberculosis ?whiB6 cells together with pGA80 [16] which provided the L5 integrase. Transformants were 
selected on 7H10 agar containing streptomycin (20 μg/ml). The empty pGA44 vector was also transformed. 
The plasmids used in this study are listed in Table 2. 
Macrophage survival  
Human monocytic THP-1 cells were grown in RPMI medium supplemented with 10% FBS. Monocytes were 
prepared at a concentration of 2x106 cells/ml and differentiated into macrophages using phorbol-12-myristate-
13-acetate (PMA) at a final concentration of 4 nM. Subsequently, 105 cells/well (50 μl/well) were pipetted into 
a 96 well-plate, the plate was sealed with a gas-permeable film and incubated at 37°C with 5% CO2 for 18h. 
Medium containing PMA was removed and replaced with 50 μl of new pre-warm RPMI medium. Bacteria 
were grown to OD600 0.4-0.8, washed, resuspended in 7H9 broth to an OD600 of 1 (3 ? 108 bacteria/ml) and 
diluted in RPMI medium at a concentration of 107 bacteria/ml. THP-1 cells were then infected at a multiplicity 
of infection (MOI) of 5 (50 μl/well of 107 bacteria/ml in RPMI) and incubated for three days at 37°C with 5% 
CO2. Afterwards, 5 μl (1:20) of PrestoBlue cell viability reagent (Life Technologies) was added to each well, 
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the plate incubated for 30 min at 37°C and the fluorescence measured using a Tecan M200 instrument 
(excitation/emission wavelength of 560/590 nm). Fluorescence values of three biological replicates (for each 
strain tested) were analyzed in GraphPad Prism (version 5) and significant differences between the conditions 
determined using one-way ANOVA followed by Turkey’s multiple comparison test. 
 ?
 
Investigation of the transcriptional regulator WhiB6 of Mycobacterium tuberculosis 
 
116 
? ???????????????????
Figure 1. ?whiB6 displays an impaired cytolytic effect. Cell 
viability of THP-1 human macrophages at 72h post-infection. 
Uninfected cells were used as a control for macrophage 
survival and the H37Rv WT strain as a positive control for M. 
tuberculosis-mediated cell-death. **** p-value<0.0001 
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Table 1  Primers used in this study. 
  
 
 
 
 
 
 
 
a Hairpin ?G was calculated using OligoAnalyzer 3.1 [17]. 
 
 
 
Table 2 Plasmids used in this study 
 
 
 
 
 
  
Primer 
name  
Sequence 5'? 3' Hairpin ?G 
(kcal.mole-1)a 
Information 
    
PS-39 ctatgccctggtactcggcggtgcgcgcactagACtc
ggagctcgccgaaccggagccgcagcaccgct 
-5.92 To eliminate the extra base (G) present in 
the whiB6 promoter of H37Rv strain. 
    
PS-40 agcggtgctgcggctccggttcggcgagctccgaGT
ctagtgcgcgcaccgccgagtaccagggcatag  
-6.23 To eliminate the extra base (G) present in 
the whiB6 promoter of H37Rv strain. 
    
PS-45 ctatgccctggtactcggcggtgcgcgcactagaGct
cggagctcgccgaaccggagccgcagcaccgct 
-7.82 To introduce the extra base (G) in the 
whiB6 promoter of Erdman strain. 
    
PS-46 agcggtgctgcggctccggttcggcgagctccgagCt
ctagtgcgcgcaccgccgagtacc agggcatag  
-7.26 To introduce the extra base (G) in the 
whiB6 promoter of Erdman strain. 
    
PS-138 agcgttgcaggttgtagcctctgccgcgaaagcTtatc
Acattaaccatagcgatgcaacagtttcctc 
-1.9 To introduce two stop codons in the 2nd 
and 3rd codons of whiB6 CDS.  
PS-135 atatcctaggatgcgatacgctttcgcggcagaggctac
aac 
NA To clone whiB6-HA into pGA44. AvrII 
restriction site. 
PS-136 gcattaattaatcaagcgtaatctggaacatcgtatgggt
atgccgattgggcagac 
NA To clone whiB6-HA into pGA44. PacI 
restriction site.  
Plasmid 
name Description  Reference 
   
pJV53 Recombineering plasmid, replicative, expression of gp60 and gp61 by 
acetamide-inducible promoter. KanR 
(van Kessel 
et al. 2008) 
   
pGA44 Integrative vector at L5 attB site, carrying the TET-PIP OFF expression system, 
StrR 
 (Kolly et 
al. 2014) 
   
pGA80  pMV261-derived vector, carrying the L5 int gene for expression in trans, 
lacking oriM, KanR  
(Kolly et 
al. 2014) 
   
pPS14 pGA44-derived vector carrying whiB6-HA under the PTR promoter, integrative, 
StrR 
In this 
study 
   
pYUB412 Integrative mycobacteria shuttle vector, L5 attB site, HygR (Bange et 
al. 1999) 
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Since the discovery of the ESX-1 secretion system, considerable research effort has focused on elucidating its 
composition, function, regulation and structure. However, the molecular mechanism underlying the ESX-1 
secretion process is still not fully understood. To further unravel its functioning, this thesis was dedicated to 
the study of various ESX-1 components within the framework of the Swiss National Science Foundation 
(SNF)-financed project entitled “Integrated investigation of the ESX-1 protein secretion system of 
Mycobacterium tuberculosis”. The present work has provided new insights into the structural component 
EccE1, the ESX-1-specific chaperone EspL and the transcriptional regulator WhiB6.  
EccE1 assembles at polar regions 
We confirmed that EccE1 is a membrane- and cell wall-associated protein required for secretion of ESX-1 
substrates and induction of host cell lysis. Based on our results, EccE1 seems to be exclusively involved in 
ESX-1-dependent activity as the deletion of eccE1 from the chromosome did not impact other bacterial 
functions such as gene expression, susceptibility to antibiotics, in vitro growth or secretion by other ESX 
systems.  
In Chapter 2 we presented a strategy to localise EccE1 by using mNeon, a fluorescent protein that can be 
visualised without overexpression. This approach allowed us to work with a fully virulent, complemented 
mutant that does not express the WT copy of EccE1 but the fusion protein EccE1-mNeon instead. As a 
consequence, all functional ESX-1 complexes assembled in the bacterium should contain EccE1-mNeon.  
Our findings indicate that EccE1 is located at the cell poles of M. tuberculosis when a functional ESX-1 system 
is present but not when the esx-1 locus is deleted, as in ??RD1. This observation suggests that EccE1 requires 
other ESX-1 proteins to assemble in a stable complex in polar regions. As EccE5 was shown to be part of the 
membrane complex of the ESX-5 secretion system [1, 2], it is very likely that the foci observed at the poles 
not only correspond to EccE1 but also to the whole ESX-1 apparatus. More evidence is required to validate the 
polar localisation of ESX-1 by detecting other components. For instance, MycP1 or EccD1 can also be tagged 
using the same strategy as presented in this study. In the case of MycP1, the ?mycP1-eccE1 mutant and the 
complementation approach generated in our lab can be used for such a purpose. Eventually, co-localization of 
various ESX-1 components by combining different fluorescent proteins may result in a powerful tool.  
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ESX-1 proteins have been identified at the poles in M. marinum and M. smegmatis [3, 4]. In many bacteria, 
polar proteins are involved in a variety of functions, including pathogenesis and secretion [5]. Interestingly, 
the type IV secretion systems were also found to assemble at polar regions in Agrobacterium tumefaciens [6]. 
A question which arises is why ESX-1 proteins preferentially localise at the cell poles. A possible explanation 
is that segregation to opposite ends ensures equal inheritance between daughter cells. Considering that polar 
regions are specific and limited areas in the bacterium, directing proteins to cell poles could also serve as a 
strategy to locally increase the concentration of different subunits. In this context, membrane curvature or 
lipids that mainly accumulate at curved membranes may also play an essential role in ESX-1 localisation [5]. 
Misfolded proteins and protein aggregates often accumulate at the poles. Therefore, special care is required 
when working with non-native or fusion proteins as artefactual localization can arise upon overexpression or 
fusion to some fluorescent tag [7].  
Isolating the membrane apparatus of the ESX-1 complex in M. tuberculosis is also an important step towards 
the elucidation of its structure. To this end, a pull-down experiment using Strep-tag labeling can be performed 
as described for M. marinum (van Winden et al. 2016; Beckham et al. 2017). Indeed, a virulent EccE1-Strep 
complemented mutant has been already generated in our laboratory following the same strategy as described 
for the EccE1-HA derivative in Chapter 2. This Strep-tagged mutant may not only be used to identify EccE1 
partners and the ESX-1 membrane complex but also to purify EccE1 directly from M. tuberculosis and perform 
structural studies using high-resolution imaging, such as Cryo-electron microscopy.  
EspL  
In Chapter 3, we demonstrated that EspL is mainly a cytosolic and partly membrane-associated protein, 
essential for stabilising EspE, EspF and EspH. In addition, EspL was shown to be important for the secretion 
of EsxA, EsxB, EspA and EspD, although EspL itself was not detected in the culture filtrates. Lack of espL 
resulted in intracellular growth defect, loss of cytotoxicity and marked reduction of innate cytokine production 
ex vivo. Interestingly, EspL interacts with EspD and controls whiB6 expression by an unknown mechanism.  
The essentiality of EspL for stabilising and secreting ESX-1-related proteins suggests that it could act as a 
chaperone of the ESX-1 apparatus with a dual role: stabilising and targeting substrates to the secretion 
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machinery. In the absence of espL, intracellular levels of EspD, EspA and EspC are not affected whereas their 
secretion is severely compromised. As EspL was also found to be a membrane-associated protein, it is plausible 
that EspL may be involved in recruiting substrates to the ESX-1 apparatus through interaction with EspD. This 
hypothesis could be tested by additional studies of the EspD point mutants previously generated by our group 
[9]. Immunoprecipitation experiments as well as mass spectrometry may reveal which amino acid residues are 
important for interaction with EspL and/or with other ESX-1 components.  
To understand the role of EspL in M. tuberculosis virulence, it is essential to investigate the contributions of 
EspE, EspF and EspH. EspF was previously shown to reduce M. tuberculosis virulence in the mouse model of 
tuberculosis when deleted [10]. Recently, EspH was investigated in M. marinum and reported to interact with 
and to stabilise EspE. Deletion of espH was shown to block EspE and EspF secretion and increase virulence 
in zebrafish larvae but not in cultured macrophages [11]. Interestingly, the effects of the espH deletion on other 
substrates such as EsxA, EsxB and EspB were minor, suggesting that there is no dependency for secretion 
between EspE/EspF and other Esp proteins [11]. An M. tuberculosis espE deletion mutant has been generated 
Figure 1. Model of EspL interactions. A) espA, espC and espD are paralogues of espE, espF and espH, respectively. 
B) Taken from [8]. EspH, EspD and EspL are predicted to have structural similarities with YbaB, a DNA binding 
protein. C) EspL interacts with EspD, which in turn stabilizes EspA and EspC levels [9]. Since the sequence and 
structure of EspD and EspH are similar, it is plausible that EspL may also interact with EspH. This interaction may 
explain the requirement of EspL to stabilize EspE, EspF and EspH levels in the cytosol. Thus, EspL may recognize 
ESX-1 substrates to stabilise and direct them to the secretion machinery. EspL may also directly or indirectly control 
the expression of the transcriptional regulator WhiB6. OM: outer membrane; IN: inner membrane. 
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in our laboratory (data not presented here) and will be analyzed for its ability to secrete ESX-1 substrates and 
cause toxicity in the macrophage.  
Altogether, EspL seems to be important not only for EspE, EspF and EspH stability but also for secretion of 
other ESX-1 substrates. Therefore, it may be part of a post-translational regulatory mechanism involving 
complex protein-protein interactions.  
WhiB6 regulator 
The transcriptional regulator WhiB6 was found to positively regulate genes within the esx-1 locus and the 
distal espACD operon. WhiB6 was also reported here to be important for M. tuberculosis virulence as its loss 
resulted in severe reduction of cytotoxicity ex vivo. 
To further define the role played by WhiB6 in M. tuberculosis virulence, it is essential to check the secretion 
profile as well as the intracellular protein levels of the knock-out mutant, as we did in Chapters 2 and 3. These 
experiments will identify deregulated proteins and discover if lack of WhiB6 also impacts the function of other 
ESX systems.  
Analyzing the global transcriptional profile of the whiB6-deficient strain by RNA-sequencing (RNA-seq) and 
mapping the binding sites of WhiB6 by Chromatin Immunoprecipitation-sequencing (ChIP-seq) will provide 
a global picture of the genes directly and indirectly regulated by WhiB6. The complemented mutant expressing 
WhiB6-HA presented in this study can be used in ChIP-seq experiments as antibodies against HA are 
commercially available and highly specific. This mutant can also represent an excellent negative control in 
pull-down experiments which aim to detect WhiB6 interactors.  
ESX-1 model 
In this study, we consistently found a strong correlation between ESX-1 functionality and cytotoxicity. 
Furthermore, we observed that ESX-1 activity is not required for uptake or intracellular survival of M. 
tuberculosis in THP-1 human macrophages.  
Disruption of the structural component EccE1 and of the chaperone EspL severely compromised secretion of 
EsxA, EsxB, EspA and EspC. In contrast, secretion of EspB was not affected by deletion of either the EccE1 
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or EspL components, implying a different mechanism of translocation or a role for EspB which goes beyond 
that of a secreted substrate. 
Secretion across the cell envelope by specialized secretion systems can occur either by a one-step or a two-
step mechanism (Chapter 1). Based on the subcellular fractionation data presented in Chapter 2, we think that 
ESX-1 secretion probably occurs in a one-step process. The ESX-1 substrate EsxB was mainly found in the 
cytosol and in the secreted fractions but not in the cell wall. If ESX-1 secretion is a two-step process, the 
substrates should be exported into the periplasmic space before being translocated across the outer membrane, 
and thus, EsxB should also be found in the cell wall fraction. The size of the ESX-5 membrane channel 
observed by negative stain electron microscopy indicates that the complex is embedded exclusively in the 
inner membrane and it does not span the mycomembrane [1]. Therefore, additional components are required 
to transport substrates across the outer membrane. Two candidates that may be involved in this process are 
EspC and EspB. EspC was proposed as a needle protein, as it polymerises upon secretion and forms filaments 
on the surface of M. tuberculosis although it does not appear to localize to the poles of the cells [12]. EspB is 
also an interesting candidate because it can form oligomers and donut-shaped particles [13, 14] and was located 
in the cell membrane and cell wall fractions in the present study (Figure 3, Chapter 2). These observations are 
compatible with EspB assembling in a multimeric complex in the cell envelope. To explore this possibility, 
EspB and its interactors could be immunoprecipitated from the cell wall fraction of a strain expressing a tagged 
version of EspB. Such a strain, carrying the Strep tag on EspB, has been constructed by other members of our 
group and will be used to this purpose. Isolating EspB from M. tuberculosis and visualising its structure by 
electron microscopy could give us a more precise idea of its natural conformation and function.  
ESX-1 visualisation 
Despite twenty years of research, type VII secretion systems are among the most poorly described secretion 
systems in bacteria. A better understanding of this apparatus requires the visualisation of the nanomachine in 
its natural setting to provide a broad view of its architecture and assembly process. Recently, the molecular 
architecture of the ESX-5 membrane complex was determined at 13 Å resolution by electron microscopy [1]. 
This study offers a valuable but yet partial understanding of the type VII structural organisation. Using 
correlation Light Electron Microscopy coupled with Cryo Focus Ion Beam milling (CryoFIB) and Cryo-
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Electron Tomography (CryoET) will offer the possibility to visualise the machinery in a life-like state inside 
intact cells at the macromolecular resolution. CryoFIB is used to prepare very thin samples (~200 nm) suitable 
for recording high-quality tomograms with CryoET. From subtomogram averaging, a sub-nanometric 3D 
volume could be solved. Both technologies were successfully employed to visualise bacterial complexes such 
as the type IV and VI secretion systems [15, 16]. The fluorescent EccE1-mNeon strain presented in Chapter 2 
can be exploited to establish the coordinates along the x,y,z axes of the assembled and active ESX-1 complex 
needed for preparing the cryo-sections before imaging.  
Finally, combining these advanced techniques with time-lapse microscopy will provide a more comprehensive 
picture model of the functional mechanisms underlying ESX secretion. 
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